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ABSTRACT 
CHARLES A. MULLEN:  Use of Bis-Phosphine Platinum-Dications as Highly 
Electrophilic Catalysts for Generation of Intermediate Carbocations in Catalysis  
(Under the Direction of Michel R. Gagné) 
 
Chiral Pt-dicationic catalysts capable of C-C bond formation with the intermediacy of 
carbocations were developed.  Similar carbocations are key intermediates in the 
biosynthesis of terpenoid natural products, and are normally generated by protonation of 
an alkene or an epoxide under careful enzymatic guidance. Under non-enzymatic 
conditions such activations of alkenes are much more difficult to control.  Synthetic Pt-
dicationic complexes were developed for selective generation of these key intermediates 
in two specific types of processes.  One, the asymmetric Prins cyclization reaction, and 
second an asymmetric oxidative cation-olefin cascade cyclization reaction that converts 
polyolefin substrates into complex polycyclic products, an analogy to steroid 
biosynthesis. 
Highly electrophilic P2Pt2+ catalysts proved to be uniquely able to catalyze a Prins 
cyclization reaction in the reaction of alkenyl phenols and glyoxylate esters.  Other chiral 
Lewis acids provided the products of a concerted glyoxylate-ene reaction.  The 
uniqueness of the reactivity to Pt-dicationic catalysts suggested that they were able to 
access trappable ionic intermediates.  This reaction was made highly enantioselective by 
employing (tol-BINAP)Pt2+ catalysts and tBu glyoxylate with various phenol substrates.   
iii 
 
The P2Pt2+ catalysts also proved capable of mediating regio- and diastereoselective 
oxidative polycyclization reactions of dienol and trienol susbtrates.  This biomimetic 
cyclization is initiated by Pt(II) activation of a less substituted alkene at the terminus of a 
polyene susbtrate and is terminated by <-hydride elimination.  This transformation was 
rendered catalytic by employing trityl cation to abstract hydride from the putative 
cationic Pt-hydride to regenerate the Pt2+ catalyst.  Good enantioselectivity could be 
achieved in this reaction by employing xylyl-PHANEHPOS as the bisphosphine ligand.  
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Chapter 1 
Cation-Olefin Cyclizations: Inspiration from Nature 
 
1.1 Enzymatic Cyclization of Squalene and Squalene Derivatives 
For pure synthetic efficiency, one of the most impressive biochemical transformations 
known is the enzyme-catalyzed cyclization of triterpenes, a ubiquitous reaction found in 
nature in organisms ranging from simple microbes to plants and animals.1 In these 
processes, carbon-carbon bond formation via cation-olefin reactions creates tetra- and 
penta-cyclic products from open chain polyolefin precursors.  The power of these 
reactions is illustrated by the various architecturally different products that enzymes can 
make remarkably efficiently and selectively from the common precursor, squalene 
(Scheme 1.1).  In plants, animals and fungi, squalene is enantioselectively epoxidized by 
squalene epoxidase to afford (3S)-2,3-oxidosqualene.  There are numerous oxidosqualene 
cyclases and each is capable of generating unique natural products including lanosterol 
and cycloartenol.  Bacteria do not epoxidize squalene prior to cation-olefin cyclization; 
rather squalene-hopene cyclase catalyzes an enantioselective, diastereoselective 
polycyclization initiated by proton transfer to the alkene at the terminus.  It is believed 
 
1.  (a)  Wendt, K. U.; Schulz, G. E.; Corey, E. J.; Liu, D. R. Angew. Chem. Int. Ed. 2000, 39, 2812 – 2833.  
(b)  Abe, I.; Rhomer, M.; Prestwhich, G. D. Chem. Rev. 1993, 93, 2189 – 2206.  (c)  Yoder, R. A.; 
Johnston, J. N; Chem. Rev. 4730, 105, 4730 – 4756.  
 
2that bacterial squalene-hopene cyclase is the common ancestor of which all the 
oxidosqualene cyclases have evolved.1c 
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A large number of cyclic products are energetically competitive from a cationic 
reaction of a polyolefin such as squalene or oxidosqualene because formation of a 6-
membered ring by intramolecular olefin addition to a carbocation is exothermic (ca. -20 
kcal/mol) and has a low barrier to activation (ca. 1 kcal/mol).2 Therefore, strict 
conformational control of the polyene substrate via substrate preorganization by the 
 
2.  Jenson, C.; Jorgensen, W. L. J. Am. Chem. Soc. 1997, 119, 10846 – 10854. 
3enzyme active site is required for high product selectivity.  For example, when 
oxidosqualene is converted to lanosterol, oxidosqualene is preorganized into a chair-boat-
chair conformation (as depicted in Scheme 1.1) prior to cyclization initiation via epoxide 
ring opening.      
1.2 Biomimetic Cation-Olefin Reactions 
Because of the high efficiency and selectivity afforded by enzymatic polyolefin 
cyclization, chemists have strived to develop synthetic processes that employ 
electrophilic reagents to activate polyolefins.  Classic methods developed for this purpose 
include activation of epoxides or acetals and dehydration of tertiary alcohols. 3,4 
Scheme 1.2 
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3. (a) Johnson, W. S. Acc. Chem. Res. 1968, 1, 1-8.  (b) Johnson, W.S. Angew. Chem. Int. Ed. Engl. 1976,
15, 9-17.  (c) Johnson, W. S.; Bartlett, W. R.; Czeskis, B. A.; Gautier, A.; Lee, C. H.; Lemoine, R.; 
Leopold, E. J.; Luedtke, G. R.; Bancroft, K. J. J. Org. Chem. 1999, 64, 9587 - 9595.  (d) Corey, E. J.; Lin, 
S. J. Am. Chem. Soc. 1996, 118, 8765 – 8766. (e) Corey, E. J.; Lee, J.; J. Am. Chem. Soc. 1993, 115, 8873 – 
8874.  (f) Mi, Y.; Schreiber, J. V.; Corey, E. J. J. Am. Chem. Soc. 2002, 124, 11290 - 11291.  (g) Corey, E. 
J.; Wood Jr., H. B. J. Am. Chem. Soc. 1996, 118, 11982-11983. 
 
4. For examples of enantioselective synthetic cation-olefin polycyclizations see Section 3.1.  
4H
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H
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H H
Z-olefn cis ringjunction  
Figure 1.1.  Stork-Eschenmoser postulate. 
In the absence of an enzyme active site, the stero- and regiochemistry of cation-olefin 
reactions is necessarily dictated by the relative energetics of polyene conformers in 
solution.  The basis for diastereoselectivity in cation-olefin reactions is the Stork-
Eschenmoser postulate,5 which states that the stereochemistry of a ring junction is 
determined by the geometry of the alkene from which it was formed (Figure 1.1).  For 
terpene structures, this leads to trans-anti-trans relative stereochemistry as a series of 6-
membered chair transition states to construct the polyene structure (Figure 1.2). 
H
H
chair-chair-chair tr ans-anti-tr ans
Figure 1.2.  Cyclization of terpenes through chair transition states leading to trans-anti-trans ring 
junctions.  
1.3 Cation Generation via Intermolecular Carbon-Carbon Bond Formation 
A key step to biomimetic polycyclization is selective cation generation.  The 
examples in Scheme 1.2 use the technique of placing functional groups in strategic 
positions on the molecule so that activation of those groups leads to cation formation at 
the desired location. Another means to generate a cation from an olefin is through an 
intermolecular carbon-carbon bond forming reaction with an electrophilic carbon source 
 
5.  (a) Stork, G.; Burgstahler, A. W. J. Am. Chem. Soc. 1955, 77, 5068-5077. (b) Eschenmoser, A.; Ruzika, 
L.; Jeger, O.; Arigoni, D. Helv. Chim. Acta. 1955, 38, 1890-1904. 
5such as an activated carbonyl.  Rychnovsky has reported a TiBr4 mediated Prins reaction6
where intermolecular attack of a vinyl ether on an activated aldehyde results in an 
oxocarbenium ion (Scheme 1.3).  Intramolecular trapping of the oxocarbenium ion by 
another alkene generates a cyclic cation followed by subsequent trapping by Br- to 
complete the reaction.   
Scheme 1.3 
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1.4 Cation Generation via +2-alkene Coordination to Pt2+ 
Highly electrophilic Pt2+ complexes selectively coordinate to less substituted alkenes 
over more highly substituted alkenes.  This G2-alkene coordination to Pt2+ can be thought 
of as an equilibrium of an G1 Pt-alkyl species with a < carbocation (eq. 1.1) 
R
Pt2+
R Pt+R
Pt+
(1.1)
 
6.  Patterson, B.; Marumoto, S.; Rychnovsky, S.D. Org. Lett. 2003, 5, 3163 – 3166. 
 
6Cyclogeneration of a subsequent carbocation has been proven possible when 1,6- and 
1,7-diene substrates are activated in this fashion.7 When <-hydride elimination inhibiting 
pincer ligated (PPP)Pt2+ is used to activate dienol substrate 1 a stable cationic polycyclic 
Pt-alkyl species is formed (Scheme 1.4).6a In this case, activation of the monosubstituted 
alkene led to carbocyclization to generate a tertiary carbocation that was trapped by the 
phenol.8
Scheme 1.4 
 
1.5 Research Objectives 
With selective carbocation generation key to initiation of biomimetic cation-olefin 
polycyclizations, we looked to generate carbocations by the methods described in 
Sections 1.4 and 1.5.  We hypothesized that useful functionalized polycyclic products 
could be obtained through reaction of a polyenol with a Lewis-acid activated carbonyl 
(eq 1.2).  Furthermore, since chiral Lewis acids are well known to achieve to high 
 
7.  (a)  Koh, J. H.; Gagné, M. R. Angew. Chem. Int. Ed. 2004, 43, 3459 – 3641.   (b) Kerber, W. D.; Koh, J. 
H.; Gagné, M. R. Org. Lett. 2004, 6, 3013-3015.  (c)  Kerber, W. D.; Gagné, M. R. Org. Lett. 2005, 7, 3379 
– 3381.  (d)  Feducia, J. A.; Campbell, A. N.; Doherty, M. Q.; Gagné, M. R. J. Am. Chem. Soc. 2006, 40,
13290 – 13297. 
 
8.   For a more in depth discussion of this reaction and its stereochemistry see Section 3.1 
O
H
(PPP)PtCH2Cl2
RT
1 eq. [(PPP)Pt][BF4]2
1 eq. Ph2NMe
O
H
+ Ph2N(H)Me
1 (96:4 dr)
P
PPh2
PPh2
Pt
2+
2 BF4
[(PPP)Pt][BF4]2
Ph
7enantioselectivity when activating prochiral carbonyl species, this was a potential route to 
an asymmetric polycyclization.  Key to generating cations via this method is to generate 
enough electophilicity through the Lewis acid/carbonyl combination to support 
carbocationic intermediates to overcome competitive concerted pericyclic reactions (i.e. 
the carbonyl-ene reaction).  Work towards generation of such carbocationic intermediates 
is presented in Chapter 2. 
R
O
R'
+
*LA O
H
O
OH
R
*
*
*
R'
*
(1.2)
Previous work had demonstrated proof of principle that phosphine ligated Pt-
dications were capable of initiating cation-olefin cyclizations (Scheme 1.4).   This 
represented a polycyclization potentially amenable to asymmetric catalysis via the use of 
chiral phosphine ligands; however, turnover to a viable catalytic cycle had not yet been 
achieved.  We looked to a simpler catalyst system employing P2Pt2+ catalysts.   This 
makes employing a chiral ligand easy, with a large number of chiral bisphosphines 
readily available.  Additionally, removing the pincer ligand allows <-hydride elimination 
to occur and for the polycyclic product to be liberated from the metal (eq. 1.3).  Studies 
towards discovering a highly selective catalyst and generating efficient turnover are 
presented in Chapter 3.  
O
H
O
H
1
P2Pt2+
*
*
*
(1.3)
 
Chapter 2 
Asymmetric Prins Cyclizations 
 
2.1 Introduction 
The Prins reaction is the nucleophilic addition of an alkene to an aldehyde with the 
generation of a cation that subsequently rearranges or is trapped.1 When used in an 
intramolecular mode, Prins cyclizations are capable of generating a wide variety of 
heterocycles, usually with net addition of an external nucleophile to the resulting 
carbocation.2 Prins reactions can also be terminated by trapping though a pendant 
nucleophile3 or through a pinacol rearrangement.1c 
Mechanistically related to the Prins reaction is the carbonyl-ene reaction, wherein a 
proton from the nucleophilic alkene is transferred to the developing charge on the carbonyl 
oxygen, thus generating a homoallylic alcohol (Scheme 2.1).  Several lines of evidence (both  
 
1.  For Prins Reaction Reviews see: (a) Adams, D.R.; Bhatnagar, S.P. Synthesis 1977, 661-672. (b) Sinder, B. In 
Comprehensive Organic Chemistry; Trost, B. M. Ed.; Pergamon Press: New York, 1991; Vol. 2, pp 527-561.  
(c) Overman, L. E.; Pennington, L. D. J. Org. Chem. 2003, 68, 7143-7157. 
 
2.   For some recent examples see: (a) Delgard, J.E.; Rychnovsky, S. D. J. Am. Chem. Soc. 2004, 126, 15662-
15663.  (b) Jasti, R.; Vitale, J.; Rychnovsky, S. D. J. Am. Chem. Soc. 2004, 126, 9904-9905.  (c) Miranda, P. O.; 
Díaz, D. D.; Padrón, J. I.; Ramíez, M. A.; Martín, V. S. J. Org. Chem. 2005, 70, 57-62.  (d) Miranda, P. O.; 
Díaz, D. D.; Padrón, J. I.; Bermejo, J.; Martin, V. S. Org. Lett. 2003, 5, 1979-1982. (e) Yang, X.; Mague, J. T.; 
Li, C. J. Org. Chem. 2001, 66, 739-747.  (f) Yadav, J. S.; Reddy, M. S.; Prasad, A. R. Tet. Lett. 2005, 46, 2133-
2136. (g)  Yu, C.; Yoon, S.; Hong, Y.; Kim, J. Chem. Commun. 2004, 1840-1841. (h) Chan, K. P.; Loh, T. P. 
Tet. Lett. 2004, 45, 8387-8390. (i) Hart, D. J.; Bennett, C. E. Org. Lett. 2003, 5, 1499-1502. 
 
3.   Mikami , K.; Shimizu, M. Tetrahedron 1996, 52, 7287-7296. 
9Scheme 2.4 
+ O
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experimental4 and computational5) suggested that in contrast to thermal conditions, Lewis 
acid accelerated –ene reactions6 could proceed via stepwise mechanisms, through a discrete 
cationic intermediate prior to proton transfer  (Scheme 2.2).   
One such study compared kinetic isotope effects of a thermally induced –ene reaction of 
2-methallylbenzene and oxodiethyl malonate (Scheme 2.3).4d The observation of 
Scheme 5.2 
H
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H O
O
H
R H
H
R
R
H
H
O
H
R
concerted
step-wise
4. Mikami, K.; Wakabayashi, H; Nakai, T. J. Org. Chem. 1991, 56, 4337-4339. (b) Song, Z.; Beak, P. J. Am.
Chem. Soc. 1990, 112, 8126-8134. (c) Snider, B. B.; Ron, E. J. Am. Chem. Soc. 1985, 107, 8160-8164. (d)
Stephenson, L. M.; Orfanopoulos, M. J. Org. Chem. 1981, 46, 2200-2201.
5. Yamanaka, M.; Mikami, K. Helv. Chim. Acta. 2002, 85, 4262-4271.  (b) Mikami, K.; Ohmura, H.; 
Yamanaka, M. J. Org. Chem. 2003, 68, 1081-1085. (c)  Morao, I.; McNamara, J. P.; Hillier, I. H. J. Am. Chem. 
Soc. 2003, 125, 628-629. 
 
6.  For reviews on the -ene reaction, see: (a)  Mikami, K.; Nakai, T.; In Catalytic Asymmetric Synthesis, Second 
Edition; Ojima, I., Ed.; Wiley-VCH: New York, NY, 2000; pp 543-568.  (b) Dias, L. C. Curr. Org. Chem. 
2000, 4, 305-342.  (c)  Santelli, M.; Pons, M. Lewis Acids and Selectivity in Organic Synthesis; CRC Press, Inc.: 
Boca Raton, FL, 1995.
10
a kinetic isotope effect of 3.3 for the thermal reaction and virtually no isotope effect for the 
catalyzed reaction suggested that proton transfer to the carbonyl oxygen was involved in the 
rate determining step of the reaction in the thermal case and not involved in the catalytic 
case.  This suggested that in the catalyzed reaction carbon-carbon bond formation is rate-
determining and is followed by a rapid proton transfer; while in the thermal case a concerted 
pathway is followed. 
Scheme 2.6 
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Conceptually related to this notion is the reaction shown below, which was simply termed 
a Lewis acid catalyzed –ene reaction, but given the possibility of step-wise reactivity, it could 
also result from interception of an intermediate cation (eq. 2.1).7 Ethylene carbonate was 
found to be the optimal for good yields of product, providing circumstantial evidence for the 
involvement of cations.8
H
O
H
H
SnCl4
O O
O
3 min
00 C
HO
H
H
H
H
(2.1)
 
Another relevant example is the SnCl4-mediated Prins cyclization of silyl protected 
pentenols (Scheme 2.4).3 Mikami noted that Me2iPrSi- protecting groups optimally provided 
 
7.   Zielgler, F. E.;Wang, T. F. J. Am. Chem. Soc. 1984, 106, 718-721. 
 
8.   Ethylene carbonate is a key cosolvent in many of the cationic cyclizations developed by W. S. Johnson: 
McCarry, B. E.; Markezich, R.; Johnson, W. S. J. Am. Chem. Soc. 1973, 95, 4416-4417. 
11
the Prins product with the –ene product being a minor byproduct (<30%).  Other 
combinations of protecting groups, tether length, and Lewis acid either led to decomposition 
or –ene products.  Based on the effect of substitutents on the cyclization diastereoselectivity, 
a model explaining each position’s orientational preference was presented. 
Scheme 2.7 
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Mikami model for stereocontrol
in SnCl4-mediated Prins cyclizations  
While many excellent catalysts have been developed for enantioselective ene-reactions 
(and especially for glyoxylate-ene reactions5,9), an asymmetric variant of the Prins 
cyclization was unknown.  We reasoned that a suitable catalyst could generate a trappable 
form of the step-wise –ene reaction intermediate cation, and therefore initiated a search for 
such a species.  We began our investigation with the Lewis acid catalyzed reaction of 2-
prenyl phenol (1) and the chelating aldehyde ethyl glyoxylate.  While most of the Lewis 
acids provided predominantly the –ene product 2, (bisphosphine)Pt2+ ligands provided 
chroman 3 (eq 2.2).  Refining the catalyst and reaction conditions led to a highly 
enantioselective variant.    
O
H
+
OO
H OEt
10% Lewis Acid
OH
CO2Et
O
H
O
CO2Et
OH
1 2 3b
-ene Prins
(2.2)
 
9.   Examples with various catalysts:  (a) Mikami, K.; Terada, M.; Nakai, R.; J. Am. Chem. Soc. 1990, 112,
3949-3954.  (b)  Evans, D. A.; Tregay, S. W.; Burgey, C. S.; Paras, N. A.; Vojkovsky, T. J. Am. Chem. Soc. 
2000, 122, 7936-7943.  (c) Hao, J.; Hatano, M.; Mikami, K. Org. Lett. 2000, 2, 4059-4062.  (d)  Koh, J. H., 
Larsen, A. O.; Gagné, M.R. Org. Lett. 2001, 3, 1233-1236.   
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This chapter describes the development of catalyst and conditions for this reaction, scope, 
limitations and some mechanistic detail of this unique example of an enantioselective Prins 
reaction. 
2.2 Results and Discussion 
A.  Catalyst Development.  A variety of Lewis acids known to be excellent catalysts for 
the glyoxylate-ene reaction were screened (Table 2.1) for the reaction of 2-prenyl phenol (1)
and ethyl glyoxylate. In most cases, the major compound was the glyoxylate-ene product 2,
indicating that with these catalysts, proton transfer is either too fast for efficient trapping by 
the phenol or that the overall process occurs without the intermediacy of a putative 
electrophilic alkenyl carbon.  Interestingly, the Cu(II)tBuBOX-catalyzed glyoxylate-ene 
reaction, which computationally proceeds via a cationic intermediate,5c provides the –ene 
product almost exclusively.  The highly enantioselective (BINOL)TiX2 catalysts were 
completely unreactive with these substrates.  In contrast to each of these established 
catalysts, P2Pt2+ catalysts were uniquely able to generate the chroman 3 as the sole product.   
Table 2.1. Ratio of Prins:Ene Products as a Function of Catalysta
Catalyst 3:2 
(BINOL)TiCl2 -- 
Cu(OTf)2 62:38 
Sc(OTf)3 15:85 
(tBuBox)Cu(SbF6)2 2:98c
(BIPHEP)Pt(SbF6)2d 83:17 
(BINAP)Pt(SbF6)2d 100:0 
a Reaction conditions 1, 3 eq ethyl glyoxylate, 10 mol% catalyst, CH2Cl2, RT.  b Determined by GC.  c 81% ee  
 d Generated in situi from P2PtCl2 and AgSbF6
O
O
Ti
Cl
Cl
Cu
N N
O O
Me3C CMe3
2+
2 SbF6-
[(tBuBox)Cu][SbF6]2(BINOL)TiCl2
P
P
Pt
Ph2
Ph2
2 SbF6-
[(BIPHEP)Pt][SbF6]2
[(BINAP)Pt][SbF6]2
2+
 
Figure 2.1  Structures of test catalysts for Prins cyclizations.
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Because good facial control in additions to glyoxylate esters is well established for chiral 
P2Pt2+ catalysts,10 the likelihood of discovering a highly enantioselective variant of our 
catalyst was high.  We therefore did an extensive examination of readily available chiral 
diphosphines.  The results of the screening process (abbreviated list shown in Table 2.2) 
showed that ligands of the BINAP series were best for selectivity of the Prins reaction 
product 3 over the –ene product 2. Additionally, BINAP and tol-BINAP also gave the 
highest enantioselectivitites, 60%  (for one of two observed diastereomers) under these 
unoptimized reaction conditions.  
Table 2.2. Representative screen of bisphosphine ligands for Pt2+ catalyzed Prins reaction a 
P2 3:2b dr 3b % ee of 31b,c 
(R)-MeO-BIPHEP 83:17 1:1 39 
(R)-p-tBu-MeO-BIPHEP 61:39 1:1.4 32 
(R)-p-MeO-MeOBIPHEP 90:10 1.3:1 48 
(R)-p-CF3-MeO-BIPHEP 69:31 2:1 12 
(R)-3,5-Me2-MeO-BIPHEP 86:14 1.2:1 38 
(R)-Cl-OMe-BIPHEP 86:14 1.3:1 58 
(R)-BINAP 100:0 1.3:1 60 
(R)-tol-BINAP 100:0 1:1 60 
(R)-xylyl-BINAP 100:0 1.3:1 38 
(R)-PHANEPHOS 88:11 3.6:1 0 
(S,S)-CHIRAPHOS 30:70 1:1 0 
1Reaction conditions: 1, 3 eq. ethyl glyxoylate, 10% P2PtCl2, 20% AgSbF6, 1:2 ClCH2CH2Cl:toluene, RT.  b Determind by GC.  
c One (major) of two observed distereomers (vida infra). 
 
Figure 2.2. Structures of BINAP type ligands. 
 
10.  (a) Ghosh, A. K.; Matsuda, M.  Org. Lett. 1999, 1, 2157-2159. (b) Becker, J. J.; White, P. S.; Gagné, M. R. 
J. Am. Chem. Soc. 2001, 123, 9478-9479. (c) Koh, J. H.; Larsen, A. O.; Gagné, M. R. Org. Lett. 2001, 3, 1233-
1236. (d) Pignat, K.; Vallotto, J.; Pinna, F.; Strukul, G. Organometallics 2000, 19, 5160-5167. (e) Hao, J.; 
Hatano, M.; Mikami, K. Org. Lett. 2000, 2, 4059-4062. (f) Oi, S.; Tereda, E.; Ohuchi, K; Kato, T.; Tachibana, 
Y.; Inoue, T.  J. Org. Chem. 1999, 64, 8660-8662. (g) Oi, S.; Kashiwaga, K.; Inoue, Y. Tetrahedron Lett. 1998,
39, 6253-6256. (h) Doherty, S.; Goodrich, P.; Hardacre, C.; Luo, H.; Nieuwenhuyzen, M.; Rath, R. K. 
Organometallics, 2005, 24, 5945-5955. 
PAr2
PAr2
Ar = Ph BINAP
Ar = 4-MePh tol-BINAP
Ar = 3,5-Me2Ph xylyl-BINAP
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The reaction conditions were further optimized by studying the effect of various solvents. 
It was noted that the enantioselectivity was solvent dependent, and increased with decreasing 
polarity (Table 2.3), perhaps suggesting a tighter transition state structure in the less polar 
solvents; donor solvents completely inhibit catalysis.  Counterintuitive, however, was the 
shift from the Prins to the –ene product when the very polar nitromethane was used.  This 
may suggest that a stabilizing interaction between the phenol trap and developing charge on 
the alkene is important for efficient trapping.  This interaction is broken by solvation of the 
cation by very polar solvent leading to less efficient trapping; allowing the proton transfer of 
the step-wise –ene reaction to occur (see Scheme 2.2).  This hypothesis is supported by the 
observation of less  –ene product as the nitromethane is diluted with dichloromethane. 
Table 2.3. Solvent Effectsa
Solvent 9b 3:2c %ee 31c,d 
CH3NO2 38.6 33:67 0 
1:1 CH3NO2:CH2CH3 23.8 55:45 0 
1:3 CH3NO2:CH2Cl2 16.3 83:17 18 
CH2ClCH2Cl 10.4 100:0 22 
CH2Cl2 8.9 100:0 30 
PhCl 5.62 100:0 58 
PhF 5.42 100:0 54 
1:1 CH2Cl2:PhCH3 5.64 100:0 56 
1:2 CH2Cl2:PhCH3 4.55 100:0 57 
1:3 CH2Cl2:PhCH3 4.01 100:0 66 
1:7.5 CH2Cl2:PhCH3 3.88 100:0 70 
aReaction conditions:  1, 3 eq. ethyl glyoxylate, 10 mol% (R)-(BINAP)PtCl2, 20% AgSgF6, solvent, RT.  b Mixed solvente systems dielectric 
calculated by weighted avergage.  c Determined by GC.  d One of two observed diastereomers (vida infra)
Because the least polar solvent system that our (BINAP)PtCl2 catalyst precursor was 
soluble in was a 1:7.5 mixture of dichloromethane and toluene and the enantioselectivites 
increased with decreasing polarity it was desirable to synthesize an isolated dicationic 
catalyst that could be used directly in toluene and need not be activated with Ag(I) salts.  We 
therefore isolated the (tol-BINAP)Pt2+ catalyst as its bis(pentafluorobenzonitrile) adduct 
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(4).11 The complete synthesis of 4 starting from the commercial platinum source, K2PtCl4 is 
shown in Scheme 2.5.  When 10 mol% 4 was used in the reaction of 1 with ethyl glyoxylate 
in toluene, 3 was generated in 85% yield as 1:1.2 mixture of diastereomers (78 and 48% ee,
respectively).   
Scheme 2.8 
K2PtCl4
COD
(COD)PtCl2
CH2Cl2
CH2Cl2
AcOH, H2O
reflux
(R)-tol-BINAP (R)-(tol-BINAP)PtCl2
2 AgSbF6
10 NCC6F5
4
(R)-(tol-BINAP)PtCl2
P
P
Pt
NCC6F5
NCC6F5
ArAr
Ar
Ar
2 SbF6-
Ar =
2+
 
B. Scope and Limitations. To further improve the selectivity, we shifted our attention to 
the effect of the glyoxylate ester’s size on enantioselectivity.  Results (Table 2.4) showed that 
one diastereomer’s ee was much more sensitive to the size of the glyoxylate ester (24 X
94%) than the other (74 X 96%), with R = tBu giving the best selectivities for both 
diastereomers.12 Despite the sensitivity of the aldehyde’s facial bias, the diastereofacial 
selectivity of the nucleophilic alkene was largely unaffected by the glyoxylate ester 
substitutent; efforts to improve the reaction dr’s proved unsuccessful. 
The optimum catalytic system was then applied to several classes of substrates (Table 
2.5).  Results showed that several phenols were capable reactants, and provided the Prins  
 
11.  Becker, J. J.; Van Orden, L. J.; White, P. S.; Gagné, M. R. Org. Lett. 2002, 4, 727-730. 
 
12.   The relative stereochemistry was determined by nOe; absolute stereochemistry at the carbinol center was 
determined by Mosher’s ester analysis.  See experimental section. 
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Table 2.4.  Effect of Glyoxylate Ester Size.a
O
H
+
OO
H OR
10% 4
O
CO2R
OH1
R = Me 31a
R = Et 31b
R = iPr 31c
R = tBu 31d
H
O
CO2R
OH
H
R = Me 32a
R = Et 32b
R = iPr 32c
R = tBu 32d
toulene, RT
 
R 3:2b dr (31:32) %ee 3 
Me 100:0 1:1.5c 74:24b
Et 100:0 1:1.2b 78:48d
iPr 100:0 1:1b 82:86d
tBu 100:0 1:1b 96:94d
a Reaction conditions:  1, 3 eq. glyoxylate, 10 mol% 4, toluene, RT.  b Determined by GC.  cDetermined by 1H NMR  d
Determined by SFC. 
product cleanly and with good to excellent ee’s.  The nucleophilicity of the phenol trap, 
varied by changing the substitutent para to the phenol, made little difference in the yield of 
the chroman.  The exception to this was the tBu glyoxylate/5 (entry 2) combination, which 
gave numerous unidentified products; ethyl glyoxylate/5 (entry 3), however, was well 
behaved and gave products in the expected ee range. 
A 1,1-disubstituted olefin was also tested (entry 5) and although the expected benzofuran 
Prins product was obtained, the yields were diminished because of competing –ene 
chemistry.   Additionally, p-OMe styryl groups are competent nucleophiles providing the aryl 
substituted chroman in good yield and ee (entry 6). 
The unsubstituted 2-cinnamyl phenol (13) (entry 7), however, was unreactive under the 
standard conditions, thus bracketing the nucleophilicity necessary for addition.13 The 
insufficient nucleophilicity of the cinnamyl case could be compensated for by the addition of 
small amounts of Brønsted acid co-catalyst (0.05% HOTf).  Although the acid sensitivity of  
 
13.  Mayr, H.; Kempf, B.; Ofial, A. R. Acc. Chem. Res. 2003, 36, 66-77. 
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Table 2.5.  Asymmetric Prins Cyclizations 
OH
OH O
CO2But
HO
OH
X = H 31d, 32d
X = OMe 6b,d1, 6b,d2
X = Cl 81, 82
CH3
101,102
121,122
X
O
CO2But
H
OH
O
CO2But
H
OH
Ar
X = H (1)
X = OMe (5)
X = Cl (7)
76%
---
60%
72%
96:94
92:90
76:48
92:88
(9) 42% 53:88
OMe
(11) 81% 92:97
Alkene Product Yielda %ee(1:2)bGlyoxylate
tBu
tBu
Et
tBu
tBu
tBu
OH O
CO2Et
H
OH
Ph
(13) Et 84% 68
OH
Et 0% ------
OH
14
X
Et --- 0% ---
1
2
3
4
5
6
7d
8
9
7.5:1 d.r.
OH
Et 0% ------10
d
dr
1:1
---
1:1
1.9:1
1.2:1
1:1
7.5:1
---
---
---
OH
11 tBu MultipleProducts
--- --- ---
a Isolated.  b enantioselectivities for the two diastereomers (see Experimental).  c This substrate yielded only traces of product     
with tBu glyoxylate but reacted cleanly with ethyl glyoxylate.  d with 0.05% added HOTf. 
the t-butyl ester precluded the use of tBu glyoxylate, a successful and moderately 
diastereoselective (7.5:1) Prins reaction was achieved with 13 and ethyl glyoxylate.14 We 
 
14.  The facial selectivity at the aldehyde is somehow reversed in this case, which provides 14 with the opposite 
absolute configuration at the carbinol center. 
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hypothesize that double activation15 of the glyoxylate ester (H+ and Pt2+; see below) lowers 
the threshold nucleophilicity required for addition. The observation of moderate 
enantioselectivity (68%) precludes the possibility of pure Brønsted acid catalysis.  Allyl, 
crotyl, and styrene nucleophiles were not competent (entries 8-10), even with added Brønsted 
acid, confirming the notion of a minimum alkene nucleophilicity for accessing cationic  
intermediates.13 
O
Pt
O
OEtH
H
P P 3+
• doubly activated
 aldehyde
Figure 2.3. Proposed activation of glyoxylate by P2Pt2+ and H+.
Attempts at initiating a polycyclization with a dienol substrate (entry 11) were 
unsuccessful.  The observation of numerous products suggested that there was little or no 
selectivity for which of the two substrate alkenes reacted even when bulky tBu glyoxylate 
was used.  Combined with multiple diastereomers possible and competing –ene reactions 
made type of reaction unsuitable for polycyclization. 
C.  Mechanistic Considerations. Two reasonable possibilities exist for the observed 
reactivity.  1) P2Pt2+-Lewis acids efficiently accessed the ionic intermediate and established 
conditions for phenol trapping to be more rapid than proton transfer; and 2) that the reaction 
initially goes via a classic –ene pathway, but that the P2Pt2+ additionally functions as a good 
Brønsted-Lewis Acid (eq. 2.3) to isomerize 2 to 3 (or that 2 is isomerized 3 by another 
mechanism under the reaction conditions).  The fact that 2 is not observed during the reaction 
 
15. For examples of double activation in carbonyl addition reactions, see: (a)  Aspinall, H. C.; Bissett, J. S.; 
Greeves, N; Levin, D. Tet. Lett. 2002, 43, 319-321.  (b)  Vaugeois, J.; Simard, M.; Wuest, J. D. Coord. Chem. 
Rev. 1995, 145, 55-73.  (c) Wuest, J. D. Acc. Chem. Res. 1999, 32, 81-89.  (d) Gravel, M.; Lachance, H.; Lu, X.; 
Hall, D. G. Synthesis 2004, 1290-1302. 
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catalyzed by 4 and that control experiments show that 2 is not converted to 3 under the 
reaction conditions, strongly suggest that case 1) is dominant. 
Pt
O O
OR
P P
O
O
H
H+ or Pt2+
O
OH
CO2R
2+
-ene
O
H
H
O
H
PtP2
2+
(2.3)
 
The observation of good enantioselectivity yet poor diastereoselectivity in these reactions 
is difficult to rationalize.  From the data, it appears that a bulky glyoxylate -OR group works 
with the chiral diphosphine to create an environment with a good carbonyl facial bias,  
however, this arrangement communicates little diastereofacial selectivity onto the prochiral 
alkene nucleophiles. 
D. Carbocation Rearragments.  The observation that the Prins cyclization trapping of a 
carbocation appeared to be unique to the use of P2Pt2+ catalysts led us to investigate the 
possibility of using such a generated cation to initate a pinacol rearragment.  Several allyl 
alcohol and allyl silyl ether substrates were prepared reasoning that the carbocation generated 
from nucleophilic attack of the alkene on the aldehyde could be quenched via a hydride or 
alkyl shift to generate the more stable oxocarbenium ion with transfer of H+ (or R3Si+) to the 
aldehyde oxygen to generate a new carbonyl (Scheme 2.6).  Unfortunately, most of the 
substrates gave products of –ene reactions or decomposed via dehydration of the allyl alcohol 
(examples in Scheme 2.7).   
Scheme 2.9 
OH(SiR3)
R +
OO
H OR'
P2Pt
2+
OH(SiR3)
O O
OR'
P2
Pt
R
O
R OH(SiR3)
CO2R'
20
Reasoning that cations were in fact generated, but that the step-wise –ene proton transfer 
was a faster route than the desired pinacol rearrangement, we devised substrates that 
incorporated an element of ring strain, providing a driving force for ring-expanding pinacol 
rearragment.  Allyl cyclobutanol substrates 15-17 were prepared with this notion in mind.  
Reaction with 3 eq. ethyl glyoxylate in the presence of 10% 4 led to the [-hydroxy ester 
substituted cyclopentanone products 18-20, as  mixtures of diastereomers (Scheme 2.8). The 
yields of the cyclopentanone products increased with the ability of the alkene substituent to 
stabilize a cation.  
Scheme 2. 10 
OH
10% 4 O
CO2Et
+
toluene, RT
via -ene and dehydrat ion
OTES
10% 4
OTES
OH
CO2Et
+
toluene, RT
-ene
OO
OEtH
OO
OEtH
Scheme 2.11 
OH
10% 4
O
R
HO CO2Et
+
R = Me 18 42% yield (1.2:1 dr )
R = Ph 19 65% yield (1.5:1 dr )
R = p-OMe-Ph 20 86% yield (1.7:1 dr )
toluene, RT
OH R
R
O
O
EtO
Pt
R = Me 15
R = Ph 16
R = p-OMe-Ph 17
OO
OEtH
Another example of the use of ring strain as a driving force for promoting the 
rearrangement of a carbocation is the use of the natural bicyclic product [-pinene as a 
substrate.  The reaction of [-pinene and ethyl gyloxylate in the presence of 10% 4 yielded 
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numerous isomeric products of the addition of [-pinene to ethyl glyoxylate.  Optimization of 
the reaction conditions allowed isolation of the major product (21) in 54% yield.  A plausable 
mechanism for the formation of 21 is given in Scheme 2.9 and includes key steps of cation 
generation, C-C shifting, ring expansion/contraction and cation trapping by a platinum 
alkoxide.  Further supporting the notion that P2Pt2+s are unique in their ability to generate the 
products of carbocation generation is the observation that when the catalyst is changed in this 
reaction from 4 to [(tBu-Box)Cu][SbF6]2 the –ene reaction adduct 22 is obtained in 86% 
yield (Scheme 2.9).  Since significant ring strain (i.e. chemical potential) is incorporated into 
this starting alkene, this reaction can be view as a sensitive probe for the generation of ionic 
species during the –ene reaction.  As previously mentioned, despite computional evidence 
that (tBu-Box)Cu2+ catalyst mediate the –ene reaction via cationic intermediates, these 
charge sensitive substrates do not report in any charge build up at the key tertiary center. 
Scheme 2.12 
O
EtO2C
+
toluene, 50°C
21 54%
10% 4
O
O
P2
Pt O
O
OEt
P2Pt
H
O
O
OEt
P2Pt
-pinene
OO
OEtH
+
CH2Cl2, RT
10% [(tBuBox)]Cu[SbF6]2
OO
OEtH
OH
EtO2C
22 86%  
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2.3 Conclusion 
The first example of an asymmetric Prins reaction has been developed using P2Pt2+ 
cataysts.  For the reaction of alkenyl phenols with glyoxylate esters, excellent 
enantioselectivites were achieved using tol-BINAP as the chiral bis-phosphine ligand.  This 
reaction was made possible because the highly Lewis acidic P2Pt2+ catalysts were uniquely 
able to generate trappable carbocationic intermediates in analogy to the step-wise carbonyl–
ene reaction pathway, while other Lewis acid catalysts gave the products of –ene ractions.  
Carbocation rearrangements were also possible, provided that strain relief was incorporated 
in the design of substrates to make the rearrangements faster than competing step-wise –ene 
proton transfer.   Poor diastereoselectivity and lack of selectivity for nucleophilic alkenes 
made this method not useful for polycyclization.   An [-pinene based method has also been 
developed for examining the degree of charge buildup during –ene type reactions.  When 
charge buildup is significant then strain releasing C-C bond formation/breakage events occur.   
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2.4 Experimental 
General Proceures: 
Methyl glyoxylate was prepared according to a literature procedure16 and freshly distilled 
from P2O5 prior to use.  Ethyl glyoxylate was purchased from Lancaster and freshly distilled 
prior to use by the method of Evans.17 Isopropyl glyoxylate and tert-butyl glyoxylate were 
prepared according to a literature procedure16 and purified/cracked by the following method: 
5 g glyoxylate was refluxed in 75 mL benzene in the presence of 2 mg pyridinium tosylate 
for 1 h.  The benzene/water azeotrope and excess benzene were distilled off at a bath 
temperature of 95 °C.  Then the bath temperature was raised to 115 ºC for 1 h.  Distillation at 
reduced pressure yielded a mixture of glyoxylate and benzene the proportions of which could 
be measured by 1H NMR (generally 50-70% glyoxylate).  Substituted 2-allyl phenols (1, 5, 7,
9, and 11)18 and (cod)PtCl219 were prepared according to literature procedures.  (R)-tol-
BINAP was purchased from Strem and used as received.  Toluene and CH2Cl2 were passed 
though a column of alumina, and freeze-pump-thaw degassed prior to use.  All other 
chemicals were purchased from Aldrich and used as received.  All Prins cyclization reactions 
were performed under N2 using standard Schlenk techniques.  NMR chemical shifts are 
reported in ppm and referenced to residual solvent peaks (1H and 13C) or to an external 
standard (85% H3PO4, 31P) (CFCl3, 19F).  SFC was performed on a Berger Mini-Gram.  GC 
 
16.   Kelley. T. R.; Schmidt, T. E.; Haggerty, J. G. Synthesis, 1972, 544-545. 
 
17.  Evans, D. A.; Burgey, C. S.; Paras, N. A.; Vojkovosky, T.; Tregay, S. W. J. Am. Chem. Soc. 1998, 120,
5824-5825. 
 
18.  Yamad, S.; Ono, F.; Katagiri, T.; Tanaka, J. Bull. Chem. Soc. Jap. 1977, 50, 750-755. 
 
19.  Drew, D.; Doyle, J. R. Inorg. Syn. 1990, 28, 346-349. 
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was performed on an HP-6890.  Elemental analysis was preformed by Robertson Microlit 
Laboratories, Inc. (Madison, NJ). 
(R)-[(tol-BINAP)Pt(NCC6F5)2][SbF6]2 (4). To a stirring solution of 275.8 mg (0.737 
mmol) of (cod)PtCl2 in 20 mL of CH2Cl2 was added dropwise 500.0 mg (0.737 mmol) of 
(R)-tol-BINAP in 20 mL CH2Cl2. After 30 min of stirring the solvent was removed in vacuo 
and the yellow solid precipitated from CH2Cl2/hexanes to yield 602 mg (86% yield) of (R)-
(tol-BINAP)PtCl2 as a white powder.  (R)-(tol-BINAP)PtCl2 (560 mg, 0.593 mmol) and 
448.3 mg (1.30 mmol) of AgSbF6 were then taken up in 50 mL CH2Cl2 under N2 in a flask 
protected from light.  Pentafluorobenzonitrile (747 µL, 5.93 mmol) was added and the 
mixture was stirred for 3 h.  The reaction mixture was opened to the atmosphere and filter 
through a 0.45 µm PTFE filter and the solvent removed in vacuo. The oily residue was then 
precipitated from CH2Cl2/hexanes to yield 925 mg (90% yield) of white powder.  31P NMR 
(162 MHz, CD2Cl2) ` -0.4 (s, JP-Pt = 3719 Hz).  19F NMR (376 MHz, CD2Cl2) ` -127.2 (2F), -
135.6 (1F), -157.0 (2F).  1H NMR (400 MHz, CD2Cl2) ` 7.76 (m, 7H), 7.70 (d, J = 8.4 Hz, 
4H), 7.56 (m, 5H), 7.46 (d, J = 7.6 Hz, 5H), 7.25 (t, J = 8.0 Hz, 3H), 6.75 (d, J = 8.8 Hz, 
4H), 2.40 (s, 6H), 2.01 (s, 6H).  13C{1H, 31P} NMR (76 MHz, CD2Cl2) ` 144.6, 143.6, 139.7, 
135.3, 134.9, 134.8, 129.9, 130.3, 130.1, 128.5, 127.3, 122.0, 120.6, 114.5, 112.1, 21.4, 21.3.  
Anal. Calcd. for C62H40F22N2P2PtSb2: C, 43.01; H, 2.33, N 1.62.  Found:  C, 43.05, H, 2.45, 
N, 1.77. 
Prins Cyclizations: 
General: To a stirring suspension of 4 (69.4 mg, 0.040 mmol) in 2 mL toluene was added 
1.2 mmol glyoxylate (prepared according to procedure described in general procedures).  
After 30 min of stirring the now homogeneous solution was transferred via syringe into 
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another flask under N2 containing 0.40 mmol substrate (1, 5, 7, 19, 11 or 13) and 40 µL of a 
0.05 M solution of 2,6-ditertbutyl-4-methyl pyridine (0.002 mmol) in CH2Cl2. In the case of 
11 the 2,6-ditertbutyl-4-methyl pyridine was replaced with 4 µL of a 0.05 M solution of 
HOTf (0.0002 mmol) in CH2Cl2. This solution was stirred overnight.  The solvent was 
removed in vacuo and the residue purified by flash chromatography on silica gel.    
Repeated chromatography was sometimes necessary to separate diastereomers. Unless 
otherwise noted, yields are reported for mixtures of diastereomers and NMR data is for 
diastereo-pure materials.   
Methyl 2-(2,2-dimethylchroman-3-yl)-2-hydroxyacetate (3a):  81 mg, 81% yield.  
Anal. Calcd. for C14H18O4: C, 67.18; H, 7.25.  Found: C, 67.16; H 7.26.  31a.  Enantiomeric 
excess determined by GC tR 49.3 (major); tR 53.6 (minor) [SupelCo, <-dex 120(30 M x 0.25 
mm), H2, 150°C, 20 psi) as 74%.  [[]25 = -15.32 (c 0.50, MeOH).  1H NMR (400 MHz, 
CDCl3): ` 7.07 (t, J = 8.0 Hz, 1H), 7.01 (d, J = 7.2 Hz, 1H), 6.79 (m, 2H), 4.52 (dd, J = 4.8,
1.6 Hz, 1H), 3.81 (s, 3H), 2.92 (dd, J = 17.6, 13.6 Hz, 1H), 2.87 (d, J = 4.8 Hz, 1H), 2.27 (m, 
2H), 1.54 (s, 3H), 1.30 (s, 3H).  13C NMR (100 MHz, CDCl3): ` 175.3, 153.2, 129.4, 127.4, 
121.1, 120.0, 117.2, 77.2, 69.8, 53.1, 44.0, 27.6, 21.9, 21.6.  32a. Enantiomeric excess 
determined by GC tR 56.8 (major); tR 57.9 (minor) [SupelCo, <-dex 120(30 M x 0.25 mm), 
H2, 150°C, 20 psi) as 24%.  [[]25 = +3.21 (c 0.50, MeOH).  1H NMR(400 MHz, CDCl3): `
7.05 (m, 2H), 6.81 (dt J = 7.2, 1.2 Hz, 1H), 6.75 (d, J = 8.4 Hz, 1H), 4.25 (t, J = 3.2 Hz, 1H), 
3.73 (s, 3H), 2.94 (dd, J = 16.4, 11.2 Hz, 1H), 2.84 (d, J = 6.0 Hz, 1H), 2.70 (dd, J = 16.4,
5.2 Hz, 1H), 2.35 (m, 1H), 1.40 (s, 3H), 1.31 (s, 3H). 13C NMR (100 MHz, CDCl3) ` 174.8, 
153.5, 129.9, 127.1, 120.7, 120.1, 117.0, 72.3, 70.3 52.4, 44.7, 27.4, 26.7, 22.4. 
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Ethyl 2-(2,2-dimethylchroman-3-yl)-2-hydroxyacetate (3b).  90 mg, 85% yield.  Anal. 
Calcd. for C15H20O4: C, 68.16; H, 7.36.  Found: C, 68.16; H, 7.73.  31b.  Enantiomeric excess 
determined by SFC (220 nm, 35 ºC): tR 8.1 min (major); tR 7.5 min (minor) [Chiracel OD-H 
(0.46 cm x 25 cm) CO2/MeOH 97/3, 1.5 mL/min] as 78% ee. [[]25 = -20.91 (c 0.35, MeOH).  
1H NMR (400 MHz, CDCl3) ` 7.07 (t, J = 7.6 Hz, 1H), 7.02 (d, J = 6.8 Hz, 1H), 6.81 (t, J =
7.6 Hz, 1H), 6.78 (d, J = 8.4 Hz, 1H), 4.49 (dd, J = 4.8, 1.6 Hz, 1H), 4.25 (m, 2H), 2.26 (m, 
2H), 2.92 (m, 2H), 2.28 (m, 2H), 1.54 (s, 3H), 1.29 (s, 3H), 1.28 (t, J = 7.2 Hz, 3H); 13C
NMR (100 MHz, CDCl3) ` 174.9, 153.3, 129.4, 127.3, 121.2, 119.9, 117.2, 69.7, 62.4, 44.0, 
27.6, 21.8, 22.6, 14.6. 32b. Enantiomeric excess determined by SFC (220 nm, 35 ºC): tR 12.1 
min (major); tR 11.3 min (minor) [Chiracel OD-H (0.46 cm x 25 cm) CO2/MeOH 97/3, 1.5 
mL/min] as 44% ee. [[]25 = +16.62 (c 0.60, MeOH). 1H NMR (400 MHz, CDCl3) ` 7.05
(m, 2H), 6.81 (dt J = 7.2, 1.2 Hz, 1H), 6.75 (d, J = 8.4 Hz, 1H), 4.20 (m, 3H), 2.94 (dd, J =
16.4, 11.2 Hz, 1H), 2.84 (d, J = 6.0 Hz, 1H), 2.70 (dd, J = 16.4, 5.2 Hz, 1H), 2.35 (m, 1H), 
1.40 (s, 3H), 1.32 (s, 3H), 1.30 (t, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3) ` 174.7, 153.2, 
129.2, 127.4, 120.9, 120.0, 117.0, 72.3, 62.0, 44.7, 27.8, 26.6, 22.2, 14.0. 
Isopropyl 2-(2,2-dimethylchroman-3-yl)-2-hydroxyacetate (3c):  90 mg, 81% yield.  
Anal. Calcd. for C16H22O4: C, 69.04; H, 7.97.  Found C, 69.14; H, 7.87.  31c: Enantiomeric 
excess determined by SFC (220 nm, 35º C): tR 9.0 min (major); tR 7.7 min (minor) [Chiracel 
OD-H (0.46 cm x 25) CO2/MeOH 98.5:1.5, 1.5 mL/min] as 82% ee. [[]25 = -30.7 (c 0.50,
MeOH).  1H NMR (CDCl3, 400 MHz): ` 7.07 (t, J = 8.0 Hz, 1H), 7.02 (d, J = 7.6 Hz, 1H), 
6.81 (t, J = 7.2 Hz, 1H), 6.77 (d, J = 8.4 Hz, 1H), 5.11 (septet, J = 6.4 Hz, 1H), 4.43 (d, J =
4.8 Hz, 1H), 2.92 (m, 2H), 2.26 (m, 2H),  1.55 (s, 3H), 1.29 (s, 3H), 1.27 (d, J = 6.4 Hz, 3H), 
1.24 (d, J = 6.4 Hz, 3H).  13C NMR (100 MHz, CDCl3): `174.4, 153.4, 129.4, 127.3, 121.3, 
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120.0, 117.2, 76.8, 70.4, 69.8, 44.1, 27.7, 21.8, 21.7, 21.7, 21.6.  32d. Enantiomeric excess 
determined by SFC (220 nm, 35º C): tR 14.6 min (major); tR 14.0 min (minor) [Chiracel OD-
H (0.46 cm x 25 cm) CO2/MeOH 98.5:1.5, 1.5 mL/min] as 86% ee. [[]25 = +14.84 (c 0.38,
MeOH).  1H NMR (400 MHz, CDCl3) ` 7.07 (t, J = 8.0 Hz, 1H), 7.03 (d, J = 7.6 Hz, 1H), 
6.81 (dt, J = 7.6, 1.2 Hz, 1H), 6.75 (dd, J = 8.0, 0.8 Hz, 1H), 5.08 (septet, J = 6.0 Hz, 1H), 
4.15 (dd, J = 5.2, 4.0 Hz, 1H), 2.95 (dd, J = 16.8 Hz, 12.0 Hz, 1H), 2.83 (d, J = 4.0 Hz, 1H), 
2.67 (dd, J = 16.4, 5.2 Hz, 1H), 2.36 (ddd, J = 12.0, 5.2, 4.0, 1H), 1.41 (s, 3H), 1.30 (s, 3H), 
1.29 (d, J = 6.4 Hz, 3H), 1.27 (d, J = 6.0 Hz, 3H).  13C NMR (100 MHz, CDCl3): ` 174.2, 
153.2, 129.2, 127.4, 121.1, 120.0, 117.0, 76.7, 72.6, 70.3, 44.6, 27.9, 27.0, 21.2, 21.8, 21.6. 
Tert-butyl 2-(2,2-dimethylchroman-3-yl)-2-hydroxyacetate (3d): 89 mg, 76% yield.  
Anal. Calcd. for C17H24O4: C, 69.84; H, 8.27.  Found: C, 70.08; H, 7.98.  31d. Enantiomeric 
excess determined by SFC (220 nm, 35º C): tR 7.6 min (major); tR 6.7 min (minor) [Chiracel 
OD-H (0.46 cm x 25 cm) CO2/MeOH 98.5:1.5, 1.5 mL/min] as 96% ee. [[]25 = -30.7 (c
0.50, MeOH).   1H NMR (400 MHz, CDCl3) ` 7.07 (t, J = 8.7 Hz, 1H), 7.03 (d, J = 7.6 Hz, 
1H), 6.81 (t, J = 8.4Hz, 1H), 6.77 (d, J = 8.0 Hz, 1H), 4.35 (dd, J = 4.8, 2.0 Hz, 1H), 2.91 
(m, 2H), 2.25 (m, 2H), 1.54 (s, 3H), 1.47 (s, 9H), 1.34 (s, 3H).  13C NMR (100 MHz, CDCl3)
`174.0, 153.3, 129.5, 127.2, 121.4, 119.9, 117.2, 83.3, 70.0, 44.1, 28.0, 27.7, 21.5.  32d. 
Enantiomeric excess determined by SFC (220 nm, 35º C): tR 13.5 min (major); tR 12.6 min 
(minor) [Chiracel OD-H (0.46 cm x 25 cm) CO2/MeOH 98.5:1.5, 1.5 mL/min] as 94% ee.
[[]25 = +14.84 (c 0.38, MeOH). 1H NMR (400 MHz, CDCl3) ` 7.07 (t, J = 7.2 Hz, 1H), 7.03 
(d, J = 8.0 Hz, 1H), 6.82 (t, J = 8.4 Hz, 1H), 6.75 (d, J = 8.0 Hz, 1H), 4.01 (t, J = 4.0 Hz, 
1H), 2.96 (dd, J = 16.8, 12.0 Hz, 1H), 2.88 (d, J = 5.2 Hz, 1H), 2.70 (dd, J = 16.8, 5.6 Hz, 
1H), 2.32 (ddd, J = 11.6, 5.2, 3.6 Hz, 1H), 1.47 (s, 9H), 1.42 (s, 3H), 1.30 (s, 3H).  13C NMR 
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(100 MHz, CDCl3) `173.9, 153.3, 129.2, 127.4, 121.2, 120.0, 117.0, 83.4, 72.8, 44.6, 28.0, 
27.9, 27.1, 22.3. 
Ethyl 2-hydroxy-2-(6-methoxy-2,2-dimethylchroman-3-yl)acetate (6b):  71 mg, 60% 
yield.  Anal. Calcd. for C18H26O5: C, 67.06; H, 8.13.  Found: C, 65.45; H, 7.63.  61b.  
Enantiomeric excess determined by SFC (220 nm, 35º C): tR 9.7 min (major); tR 10.4 min 
(minor) [Chiracel OD-H (0.46 cm x 25 cm) CO2/MeOH 97/3, 1.5 mL/min] as 76% ee. [[]25 
= -32.5 (c 0.50, MeOH).   1H NMR (400 MHz, CDCl3) ` 6.67 (m, 2H), 6.57 (d, J = 2.8 Hz, 
1H), 4.47 (dd, J = 4.8, 1.6 Hz, 1H), 4.26 (m, 1H), 3.72 (s, 3H), 2.89 (m, 2H), 2.26 (m, 2H), 
1.52 (s, 3H), 1.29 (s, 3H), 1.28 (t, J = 6.4 Hz. 3H).  13C NMR (CDCl3, 100 MHz) ` 174.9, 
153.1, 147.2, 121.8, 117.7, 113.9, 113.5, 76.6, 69.7, 62.4, 55.7, 44.0, 27.6, 22.2, 21.5, 14.2.  
62b. Enantiomeric excess determined by SFC (220 nm, 35º C): tR 14.5 min (major); tR 18.6 
min (minor) [Chiracel OD-H (0.46 cm x 25 cm) CO2/MeOH 97/3, 1.5 mL/min] as 44% ee.
[[]25 = +18.6 (c 0.45, MeOH).   1H NMR (400 MHz, CDCl3) ` 6.67(m, 2H), 6.57 (s, 1H), 
4.20(m, 3H), 3.72 (s, 3H), 2.92 (dd, J = 16.8, 11.6 Hz, 1H), 2.83 (d, J = 5.6 Hz, 1H), 2.35 (m, 
1H), 1.38 (s, 3H), 1.29 (s, 3H), 1.28 (t, J = 4.6 Hz, 3H).  13C NMR (CDCl3, 100 MHz) `
174.7, 153.1, 147.1, 121.5, 117.6, 113.6, 113.5, 76.4, 72.3, 62.0, 55.7, 44.6, 27.7, 27.0, 22.2, 
14.0. 
Tert-butyl 2-(6-chloro-2,2-dimethylchroman-3-yl)-2-hydroxyacetate (8d):  94 mg, 
72% yield. Anal. Calcd. for C17H23ClO4: C, 62.48; H, 7.09.  Found: C, 62.76; H, 7.10.  
81d:  Enantiomeric excess determined by SFC (220 nm, 35º C): tR 8.4 min (major); tR 7.9 
min (minor) [Chiracel OD-H (0.46 cm x 25 cm) CO2/MeOH 98.5/1.5, 1.5 mL/min] as 92% 
ee. [[]25 = -44.7 (c 0.60, MeOH). 1H NMR (400 MHz, CDCl3) ` 7.01 (m, 2H), 6.69 (d, J =
8.0 Hz, 1H), 4.33 (dd, J = 4.4, 1.6 Hz), 2.95 (d, J = 4.8 Hz, 1H), 2.87 (dd, J = 18.0, 14.0 Hz, 
29
1H), 2.21 (m, 1H), 1.52 (s, 3H), 1.48 (s, 9H), 1.34 (s, 3H).  13C NMR (100MHz, CDCl3) `
173.8, 151.9, 129.0, 127.3, 124.6, 123.0, 118.5, 83.5, 69.5, 43.8, 28.0, 27.9, 27.5, 21.5.  82d:   
Enantiomeric excess determined by SFC (220 nm, 35º C): tR 13.3 min (major); tR 14.0 min 
(minor) [Chiracel OD-H (0.46 cm x 25 cm) CO2/MeOH 98.5:1.5, 1.5 mL/min] as 88% ee.
[[]25 = +19.1 (c 0.20, MeOH). 1H NMR (400 MHz,CDCl3) ` 7.02 (m, 2H), 6.80 (d, J = 6.8
Hz, 1H), 4.06 (d, J = 3.6 Hz), 2.92 (m, 2H), 2.67 (dd, J = 16.8, 5.6 Hz), 2.29 (m, 1H), 1.56 
(s, 3H), 1.49 (s, 3H), 1.34 (s,3H).  13C NMR (100MHz, CDCl3) ` 173.7, 151.9, 128.7, 127.4, 
124.6, 122.8, 118.4, 83.9, 72.6, 44.2, 28.3, 27.9, 27.0, 22.3.    
Tert-butyl 2-hydroxy-3-(2-methyl-2,3-dihydrobenzofuran-2-yl)propanoate (10):  
46.8 mg, 42% yield as an inseparable mixture of diastereomers. Enantiomeric excesses 
determined by GC: tR 58.6 min (diastereomer 1, major); tR 59.9 min (diastereomer 1, minor); 
tR 62.2 min (diastereomer 2, major); tR 64.7 min (diastereomer 2, minor) [SupelCo, <-dex 
120 (30M x 0.25mm), H2, 145°C, 20 psi) as 53% and 88% ee, respectively.  1H NMR 
(400MHz, CDCl3) ` 7.10 (m, 2H), 6.81 (m, 1H), 6.72 (t, J = 8.0 Hz, 1H), 4.26 (m, 1H), 3.38 
(d, J = 15.6 Hz, 0.5H), 3.31 (d, J = 16.0 Hz, 0.5H), 3.10 (d, J = 6.0Hz, 0.5H), 3.08 (d, J = 4.4
Hz, 0.5H), 2.97 (d, J = 16.0 Hz, 0.5H), 2.95 (d, J = 16.0 Hz, 0.5H), 2.33 (m, 1H), 1.99 (m, 
1H), 1.50 (s, 1.5H), 1.49 (s, 1.5H), 1.46 (s, 9H).  13C NMR (100 MHz, CDCl3) ` 174.2,
174.0, 158.4, 158.3, 128.0, 127.9, 127.1, 125.1, 120.2, 120.2, 116.8, 87.9, 87.8, 68.4, 44.5, 
44.4, 42.4, 41.4, 28.1, 28.0, 27.0, 26.2.  Anal. Calcd. for C16H24O4: C, 69.04, H, 7.97.  Found:  
C, 68.76, H, 7.88. 
Tert-butyl 2-hydroxy-2-(2-(4-methoxyphenyl)chroman-3-yl)acetate (12):  20 mg, 
81% yield.  Anal. Calcd. for C22H26O5: C, 71.33 H, 7.07. Found: C, 70.97, H, 7.42.  121.
Enantiomeric excess determined by SFC (220 nm, 35º C): tR 31 min (minor); tR 39 min 
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(major) [Chiracel AD-H (0.46 cm x 25 cm) CO2/MeOH 97/3, 1 mL/min] as 97% ee. [[]25 = 
-11.9 (c 1.1, MeOH).  1H NMR (400MHz, CDCl3) ` 7.43 (d, J = 8.4 Hz, 2H), `7.11 (m, 2H), 
6.95 (d, J = 8.4 Hz, 2H), 6.88 (m, 2H), 4.90 (d, J = 9.6 Hz, 1H), 3.83 (s, 3H), 3.75 (dd, J =
4.4, 2.4 Hz, 1H), 3.10 (dd, J = 13.6, 4.0 Hz, 1H), 2.87 (d, J = 4.4 Hz, 1H), 2.42 (m, 2H), 1.45 
(s, 9H).  13C NMR (100 MHz, CDCl3) ` 173.6, 159.7, 154.9, 131.0, 129.7, 128.7, 127.3, 
121.5, 120.5, 116.8, 114.1, 83.2, 79.4, 69.4, 55.4, 41.6, 28.0.  122. Enantiomeric excess 
determined by SFC (220 nm, 35º C): tR 48 min (major); tR 62 min (minor) [Chiracel OD-H 
(0.46 cm x 25 cm) CO2/MeOH 98.5/1.5, 1.5 mL/min] as 92% ee. [[]25 = +10.7 (c 0.9,
MeOH).  1H NMR (400MHz, CDCl3) ` 7.36 (d, J = 8.4 Hz, 2H), 7.09 (m, 2H), 6.90 (d, J =
8.4 Hz, 2H), 6.82 (m, 2H), 5.08 (d, J = 9.2 Hz), 3.90 (dd, J = 6.8 Hz, 3.6 Hz,1H), 3.00 (d, J =
4.0 Hz, 1H), 2.96 (dd, J = 16.0, 4.8 Hz, 1H), 2.77 (dd, J = 16.0, 4.8 Hz, 1H), 2.61 (m, 1H), 
1.45 (s, 9H).  13C NMR (100MHz, CDCl3) ` 172.8, 159.7, 154.7, 131.3, 129.4, 128.8, 127.5, 
121.2, 120.4, 116.6, 113.8, 83.6, 78.6,1.3, 55.3, 42.6, 28.1. 
Ethyl 2-hydroxy-2-(2-phenylchroman-3-yl)acetate (14):  114mg, 84% yield.  
Enantiomeric excess determined by SFC (220 nm, 35º C): tR 32.6 min (major); tR 27.9 min 
(minor) [Chiracel OD-H (0.46 cm x 25 cm) CO2/MeOH 96/4, 1 mL/min] as 68% ee. [[]25 = 
-32.7 (c 0.65, MeOH).   1H NMR (400 MHz, CDCl3) ` 7.42 (m, 2H), 7.36 (m, 3H), 7.10 (d, J
= 7.6 Hz, 2H), 6.88 (t, J = 7.2 Hz, 2H), 5.11 (d, J = 9.2 Hz, 1H), 4.01 (t, J = 3.2 Hz, 1H), 
3.96 (m, 1H), 3.79 (m, 1H), 3.03 (dd, J = 16.4, 11.2 Hz, 1H), 2.92 (m, 2H), 2.75 (m, 1H), 
1.24 (t, 5.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) ` 173.3, 154.7, 139.0, 129.4, 128.6, 128.3, 
127.9, 127.5, 121.4, 120.5, 116.6, 78.7, 71.4, 61.9, 42.0, 28.4, 13.9.  Anal. Calcd. for 
C19H20O4: C, 73.06; H, 6.45  Found: C, 72.92; H, 6.27. 
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Determination of Stereochemistry for 3a-d, 6b, 8d.: 
To assign the relative stereochemistry of products 3a-d, 7b, and 9d, we carefully 
analyzed the stereoisomers of 3a and then assigned the remainder by analogy.  To begin, the 
structures of the lowest energy conformers/rotomers were computed using Monte-Carlo 
methods (AM1, MacSpartan 04).  These structure(s) were then used to predict nOes. (Figure 
S1).  They were then compared with experimental nOes for each isolated diastereomer of 3b
and 3d, and assigned on the basis of the key differentiating nOes shown in Figure 2.1. The 
relative stereochemistry of the 3a,c-d, 7b, and 9d were assigned by analogy.  Supporting a 
“by analogy” assignment, were relative chromatographic retention times of the diastereomers 
(SFC, GC, and tlc), characteristic upfield shift of the faster eluting isomer’s carbinol 
hydrogen resonance (1H NMR), and the sign of the optical rotation (Table 2.6).  The faster 
eluting diastereomer was arbitrarily given the subscript 1 while the slower was given the 
subscript 2. These data, in combination with Mosher’s ester analysis20 to determine the 
absolute stereochemistry of the carbinol center, allowed the assignment of diastereomer #1 as 
having the S configuration at the ring junction (C3) and the S configuration at the carbinol 
center (C2); diastereomer #2 was assigned the (3R,2S) stereochemistry. 
 
O
OEt
O
OH
2
3
20.   Seco, J. M.; Quiñoá, E.; Riguera, R. Chem. Rev. 2004, 104, 17-117.
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Figure 2.3 Key nOes predicted and observed for 3a-d, 6b, and 8. Diastereomer #1 (left) and 
diastereomer #2 (right). 
Table 2.6.  Signs of optical rotations for enantioenriched Prins cyclization products. 
@ carbinol #1 Rotation #1 @ carbinol 2 Rotation #2
3a 4.51 - 4.23 + 
3b 4.35 - 4.22 + 
3c 4.43 - 4.15 + 
3d 4.35 - 4.07 + 
7b 4.48 - 4.20 + 
9d 4.33 - 4.05 + 
Determination of stereochemistry for 13 and 15. 
To assign the relative stereochemistry of products 13 and 15, we carefully analyzed the 
stereoisomers of 15. The relative stereochemistry between the ring stereocenters 3 and 4 was 
determined to be trans by the H-H coupling observed in the 1H NMR (see characterization 
data) for all products of this type.   The structures of the lowest energy conformers/rotomers 
were computed using Monte-Carlo methods (AM1, MacSpartan 04).  These structure(s) were 
then used to predict nOes. (Figure S2).  They were then compared with experimental nOes 
for each isolated diastereomer of 13 and 15, and assigned on the basis of the key 
differentiating nOes shown in Figure 2.2.   These data, in combination with Mosher’s ester 
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analysis20 to determine the absolute stereochemistry of the carbinol center, allowed the 
assignment of 151. These data, in combination with Mosher’s ester analysis to determine the 
absolute stereochemistry of the carbinol center, allowed the assignment of 131 as (4R,3S,2S), 
132 as (4S,3R,2S) and 15 as (4R,3S,2R). 
 
Figure 2.5: Key nOes predicted and observed for 13 and 15. Diastereomer #1 (left) and diastereomer 
#2 (right). 
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Carbocation Rearrangements: 
Substrate Synthesis: Cyclobutanol substrates 15-17 were prepared by addition of the 
apprioate Grignard reagent to cyclobutanone. 
1-(prop-1-en-2-yl)cyclobutanol (15):  Isopropenyl magnesium bromide (31.4 mL, 15.6 
mmol) was added to a solution of 1.0 g cyclobutanone (14.2 mmol) in 30 mL diethyl ether at 
0 °C and stirred at 0 °C for 3h.  The reaction was quenched with 15% aqueous NH4Cl and 
extracted with diethyl ether (3 x 30 mL).  The organic portions were combined, washed with 
brine, dried over MgSO4 and concentrated in vacuo. The crude material was purified by 
flash chromotography on silica gel eluted with 1:5 EtOAc:hexanes to yield 1.4 g (89% yield) 
of a colorless oil.  1H NMR (400 MHz, CDCl3): ` 5.31 (d, J = 8.8 Hz, 2H), 2.49 (m, 2H), 
2.23 (m, 2H), 1.96 (m, 1H), 1.74 (s, 3H), 1.62 (m, 1H).  13C NMR (100 MHz, CDCl3): `
149.5, 111.9, 75.2, 39.9, 27.6, 18.3. 
1-(1-phenylvinyl)cyclobutanol (16):  1,2-Dibromoethane (2.0 mmol, 0.2 mL) was added 
to a suspension of Mg turnings (40.0 mmol, 0.972 g) in THF (20 mL).  After 10 min., 2.6 mL 
-bromostyrene (20.0 mmol) in 5 mL THF was added dropwise, and the solution was  heated 
to reflux for 2 h.  The reaction was then cooled to 0°C and added via cannula filter to a 
solution of cyclobutanone (10.0 mmol, 0.8 mL) in 20 mL THF.  The solution was allowed to 
stir at this temperature for 1 h and then the reaction was quenched with 15% aqueous NH4Cl, 
and extracted with diethyl ether (3 x 30 mL). The organic layers were combined, washed 
with brine, dried over MgSO4 and concentrated in vacuo. The crude product was purified by 
flash chromatography eluted with 9:1 EtOAc:hexanes to yield  1.7g (53%) of a colorless oil.  
1H NMR (400 MHz, CDCl3): ` 7.50 (m, 1H), 7.31 (m, 4H), 5.37 (d, J = 8.4 Hz, 2H), 2.49 (m, 
35
2H), 2.26 (m, 2H), 2.00 (m, 1H), 1.93 (s, 1H), 1.63 (m, 1H).  13C NMR (100 MHz, CDCl3): `
154.2, 138.6, 128.8, 127.9, 126.7, 114.3, 86.2, 39.7, 39.4, 14.7. 
1-(1-(4-methoxyphenyl)vinyl)cyclobutanol (17):  Synthesized via a procedure similar to 
that for 16 using 1-(1-bromovinyl)-4-methoxybenzene.21 1H NMR (400 MHz, CDCl3): `
6.74 (d, J = 9.6 Hz, 2H), 6.86 (d, J = 9.6 Hz, 2H), 5.33 (d, J = 1.6 Hz, 1H), 5.28 (d, J = 1.6
Hz, 1H), 3.82 (s, 3H), 2.46 (m, 1H), 2.28 (m, 2H), 1.96 (m, 1H), 1.62 (m, 1H), 1.31 (m, 1H).  
13C NMR (100 MHz, CDCl3): ` 175.1, 174.5, 159.1, 151.7, 128.7, 127.3, 113.5, 111.4, 78.1, 
55.2, 35.7, 13.9.  
General Procedure for Prins-pinacol:  To a solution of 4 (69.4 mg, 0.04 mmol) in 2 
mL CH2Cl2 was added 1.2 mmol freshly distilled ethyl glyoxylate.  After 30 min of stirring 
the  solution was transferred via syringe into another flask under N2 containing 0.40 mmol 
substrate (15, 16, or 17) and 40 µL of a 0.05 M solution of 2,6-ditertbutyl-4-methyl pyridine 
(0.002 mmol) in CH2Cl2. This solution was stirred for 6 h  The solvent was removed in 
vacuo and the residue was purified by flash chromatography on silica gel eluting with 9:1 
hexanes:EtOAc.   
Ethyl 2-hydroxy-3-(1-methyl-2-oxocyclopentyl)propanoate (18): 36 mg (42% yield) 
as an inseparable mixture of diastereomers (1.2:1).  1H NMR (400 MHz, CDCl3): ` 4.12 (q, J
= 7.2 Hz, 2H), 3.98 (m, 0.5H), 3.80 (m, 0.5H), 2.20 (m, 8H), 1.33 (s, 1.5 H), 1.32 (s, 1.5 H), 
1.29 (m, 3H).  13C NMR (100 MHz, CDCl3):  ` 220.3, 219.2, 69.7, 69.4, 57.5, 56.8, 46.7, 
46.3, 43.1, 42.5, 37.0, 36.2, 33.9, 32.6, 31.0, 29.7, 20.7, 19.2, 18.7, 18.6, 14.2, 14.0. 
Ethyl 2-hydroxy-3-(2-oxo-1-phenylcyclopentyl)propanoate (19): 72 mg (65% yield) 
as an inseparable mixture of diastereomers (1.5:1 dr).  1H NMR (400 MHz, CDCl3): ` 7.43 
 
21.   Rappoport, Z; Gal, A. J. Chem. Soc. Perkin Trans. II, 1973, 301-310. 
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(d, J = 6.4 Hz, 2H), 7.33 (m, 2H), 7.23 (m, 1H), 4.12 (q, J = 7.2 Hz, 2H), 3.97 (m, 0.5 H), 
3.80 (m, 0.5 H), 2.91 (m, 0.5H), 2.66 (m, 1H), 2.60 (d, J = 6.4 Hz, 1H), 2.51 (dd, J = 14.4,
2.8 Hz, 1H), 2.25 (m, 6H), 2.13 (m, 2H), 1.93 (m, 2H), 1.83(dd, J = 14.4, 11.2 Hz, 1H), 1.73 
(m, 1H), 1.21 (t, J = 7.2 Hz, 3H).  13C NMR (100 MHz, CDCl3) ` 220.7, 219.1, 175.1, 174.3, 
138.6, 137.8, 128.8, 128.7, 127.1, 127.2, 126.6, 126.4, 68.9, 68.2, 61.7, 61.4, 56.9, 56.0, 43.1, 
42.2, 37.1, 36.4, 33.9, 33.9, 18.7, 18.7, 14.1, 14.0. 
Ethyl 2-hydroxy-3-(1-(4-methoxyphenyl)-2-oxocyclopentyl)propanoate (20): 105 mg 
(86% yield) as two separate diastereomers (1.7:1).  201: 1H NMR (400 MHz, CDCl3): ` 7.36
(d, J = 8.4 Hz, 2H), 6.88 (d, J = 8.4 Hz, 2H), 4.12 (d, J = 7.2 Hz, 2H), 3.86 (m, 1H) 3.82 (s, 
3H), 2.61 (m, 1H), 2.45 (m, 1H), 2.25 (m, 1H), 2.09 (m, 1H), 2.01 (m, 1H), 1.90 (m, 1H), 
1.79 (m, 2H), 1.25 (t, J = 7.2 Hz, 3H).  13C NMR (100 MHz, CDCl3): ` 219.3, 175.3, 158.7, 
128.5, 128.3, 114.2, 68.2, 61.8, 55.3, 55.2, 43.0, 36.2, 34.1, 18.7, 14.1.  202: 1H NMR (400 
MHz, CDCl3): ` 7.25 (d, J = 8.4 Hz, 2H), 6.89 (d, J = 8.4 Hz, 2H), 4.12 (m, 1H), 4.02 (m, 
1H), 3.80 (s, 3H), 3.74 (m, 1H), 2.66 (m, 1H), 2.10 – 2.45 (m, 5H), 1.95 (m, 1H), 1.74 (m, 
1H), 1.25 (t, J = 7.2 Hz, 3H).  13C NMR (100 MHz, CDCl3): 221.1, 175.3, 158.8, 129.8, 
128.1, 114.2, 68.8, 61.4, 56.3, 55.2, 42.1, 37.0, 35.9, 18.7, 14.0. 
Ethyl 5-isopropyl-2-methyl-6-oxabicyclo[3.2.1]oct-2-ene-7-carboxylate (21): To a 
solution of 4 (69.4 mg, 0.04 mmol) in 2 mL toluene was added 1.2 mmol freshly distilled 
ethyl glyoxylate.  After 30 min of stirring the solution was transferred via syringe into 
another flask under N2 containing  63.3 µL [-pinene (54.4 mg, 0.40 mmol).  This solution 
was stirred for 4 h at 50 °C.  The solvent was removed in vacuo and the residue purified by 
flash chromatography on silica gel eluting with 19:1 hexanes:EtOAc to yield 51 mg of a 
colorless oil.  1H NMR (400 MHz, CDCl3): ` 5.23 (s, 1H), 4.38 (s, 1H), 4.15 (m, 2H), 2.57 
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(d, J = 4.4 Hz, 1H), 2.20 (m, 1H), 2.07 (m, 1H), 2.00 (dd, J = 14.0, 6.8 Hz, 1H), 1.81 (ddd, J
= 10.8, 4.4, 1.2 Hz, 1H), 1.76 (m, 3H), 1.65 (d, J = 10.8 Hz, 1H), 1.54 (s, 3H), 1.25 (t, J =
5.2 Hz, 3H), 0.99 (d, J = 6.8 Hz, 3H), 0.95 (d, J = 6.8 Hz, 3H).  13C NMR (100 MHz, 
CDCl3): ` 174.9, 135.7, 123.3, 91.4, 83.9, 61.6, 52.9, 35.4, 34.8, 33.2, 21.0, 17.8, 14.1. 
Chapter 3 
Oxidative Cation-Olefin Polycyclization 
 
3.1 Introduction 
Biomimetic polyolefin cascade reactions are among the most challenging problems in 
reaction design; however, because large increases in molecular complexity can be obtained in 
a single step, chemists have strived to develop synthetic methodologies analogous to 
enzymatic processes.1,2 Methodologies previously employed include ionization of epoxides 
and acetals with Lewis acids,3 protonation of alkenes with Brønsted acids,4 and addition of 
mercuric salts to olefins.5
Recently, the reach of synthetic polycyclization reactions has been expanded to allow for 
asymmetric variation.  Yamomoto has developed chiral Brønsted-Lewis Acid (BLAs) 
 
1.  For a discussion on biosynthesis of terpenoid natural products see Chapter 1. 
 
2.  (a)  Bartlet, P. A. in Asymmetric Synthesis; Morrison, J.D.; Academic Press, Inc.: Orlando, 1984; Vol. 3, pp 
341-377.  (b)  Sutherland, J. K. in Comprehensive Organic Synthesis; Trost, B. M. and Fleming, I.; Pergamon 
Press: Oxford, Engalnd, 1991; Vol 3, pp 341 - 409. 
 
3. (a) Johnson, W. S. Acc. Chem. Res. 1968, 1, 1-8.  (b) Johnson, W. S. Angew. Chem. Int. Ed. Engl. 1976, 15,
9-17.  (c) Johnson, W. S.; Bartlett, W. R.; Czeskis, B. A.; Gautier, A.; Lee, C. H.; Lemoine, R.; Leopold, E. J.; 
Luedtke, G. R.; Bancroft, K. J. J. Org. Chem. 1999, 64, 9587 - 9595.  (d) Corey, E. J.; Lin, S. J. Am. Chem. Soc. 
1996, 118, 8765 – 8766. (e) Corey, E. J.; Lee, J.; J. Am. Chem. Soc. 1993, 115, 8873 – 8874.  (f) Mi, Y.; 
Schreiber, J. V.; Corey, E. J. J. Am. Chem. Soc. 2002, 124, 11290 - 11291.  (g) Corey, E. J.; Wood Jr., H. B. J. 
Am. Chem. Soc. 1996, 118, 11982-11983. 
 
4.  (a) Ishihara, K.; Ishibashi, H.; Yamamoto, H. J. Am. Chem. Soc. 2002, 124, 3647-3655.  (b)  Nakamura, S.; 
Ishihara, K,; Yamamoto, H. J. Am. Chem. Soc. 2000, 122, 8131-8140. 
 
5. (a) Nishizawa, M.; Takenaka, H.; Hayashi, Y. J. Org. Chem. 1996, 51, 806-813. (b) Hoye, T. R.; Kurth, M. J. 
J. Am. Chem Soc. 1979, 101, 5065 – 5067.  
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catalysts for initiation of cation-olefin polycyclization reactions.4 By combining a resolved 
BINOL derivative and a strong Lewis acid, H+ can be delivered with a preference for one 
enantioface of a polyene reactant and, thereby, initiate enantioselective cation-olefin 
polycyclization reactions (eq. 3.1).   
O
Br
15% (R)-BINOL-Bz SnCl4
-78 OC, 6 days
O
Br
H
94% yield, 90% ee
(3.1)
Very recently, Ishihara reported a halocyclization of polypreniods, where a combination 
of a chiral phosphoramidite and NIS is used to generate a chiral I+ source.  Use of these 
reagents with polyprenoid substrates afforded a mixture of trans fused halogenated bicyclic 
products and trans A ring monocyclic products in excellent ee. The monocyclic products 
can be converted to the bicyclic products by ClSO3H, to yield entirely the bicyclic product 
(Equation 3.2).6
1.1 eq NIS
1 eq O
O
P N
Ph
H
toluene, -40 0C
24 h
ClSO3H
i-PrNO2, -78 0C
4 h H
57% yield, 95% ee
(3.2)
I
From the viewpoint of biomimetic polyene cyclizations, H+ and I+, like most 
electrophiles, prefer to activate electron rich trisubstituted alkenes and are thus well suited to 
initiating cation-olefin cascades to steroid-like structures.  Since many natural products are 
geminally methylated at C-4, these efficient approaches access useful carbon skeletons. 
 
6.  Sakakura, A.; Ukai, A.; Ishihara, K. Nature 2007, 445, 900 – 903.  
40
Conversely, ionic methods do not lend themselves to direct synthesis of 4,4-unsubstituted 
(e.g. cholesterol) or 4-monosubstituted carbon skeletons since this position needs to be 
stabilized for cation generation.  This problem can be solved by oxonium ion initiation and 
subsequent functional group manipulation, however, the direct synthesis of materials without 
C-4 geminal dimethyl substitution remains a challenge. 
It was in this context that previous work focused on electrophilic Pd and Pt catalysts, 
which have a preference for less substituted alkenes and could initiate a cascade that did not 
require stabilizing substitutents at C-4.  The first evidence that Pd(II) could catalytically and 
selectivity activate terminal olefins and generate cations was reported by Overman in the 
PdCl2-catalyzed Cope-like rearrangement (Scheme 3.1).7 A cyclic cation was the proposed 
intermediate in the rearrangement; fragmentation consumed the cation and led to the diene 
product.  
Scheme 3.13 
Ph
PdCl2 PdCl2
Ph Ph
Cl2Pd
Vitaglino has reported an olefin cross dimerization that intermolecularly adds 2-
methylbut-2-ene to ethylene via a 3° cation catalyzed by a pincer complex of Pt2+.8 The key 
feature of the proposed mechanism is the selective anti carbometallation of the less 
 
7.  (a) Overman, L. E.; Knoll, F. M.; J. Am. Chem. Soc. 1980, 102, 865-867.  (b) Overman, L. E.; Jacobsen, E. J. 
J. Am. Chem. Soc. 1982, 104, 7225-7231.   
 
8.  (a) Hahn, C.; Cucciolito, M. E.; Vitagliano, A.; J. Am. Chem. Soc. 2002, 124, 9038 – 9039.  (b) Hahn, C.; 
Morvillo, P.; Hertweck, E.; Vitagliano, A.; Organometallics. 2002, 21, 1807 – 1818. 
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substituted alkene and the rearrangement of the carbocationic intermediates to expel the 
Pt(II) catalyst from the dimerization product. 
Scheme 3.14 
+
(PNP)Pt
2+
(PNP)Pt H
H
H
+
(PNP)Pt
H
H
N
PPh2
PPh2
Pt
2+
2 BF4
(PNP)Pt2+
These systems parallel cation polyene cyclizations in that carbocation intermediates are 
generated from C-C bond forming reactions, and that these intermediates undergo selective 
rearrangement and quenching.  Previous work in our group therefore focused on PdCl2 and 
pincer-Pt2+ as a potential new class of biomimetic cation-olefin cyclization catalysts.   
Presuming that the Overman mechanism for the Cope reaction (Scheme 3.1) could be 
applied to polyene cyclization the PdCl2 catalyzed cyclization of polyenes with 
intramolecular cation traps was investigated.  Utilization of the optimum conditions on 
dienyl-phenol 1 led to its clean conversion to trans-fused bicycle 2 as a mixture of olefin 
isomers (eq. 3.3).  A single product could be obtained by the hydrogenation of 2 to 3.9
9. Koh, J. H.; Mascarenhas, C.; Gagné, M. R. Tetrahedron, 2004, 60, 7405 – 7410. 
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O
H
H2 O
H
EtOH
10% (PhCN)2PdCl2
4 eq. BQ
CH3CN
80°C
(83%, 68:19:13)
Pd/C
15 h
98%, >99:1 dr
O
H
1 2 3
(3.3)
 
The course of the reaction was explained by cyclogeneration of a tertiary cation which is 
either trapped by the phenol in concert with cation generation, or very quickly thereafter 
since the cis bicycle is more stable than the observed trans.10 The resulting Pd-C bond 
undergoes <-H elimination to generate 2 as a mixture of alkene isomers; Pd(0) to Pd(II) 
oxidation with benzoquinone (BQ) closes the cycle. 
In addition to PdCl2 catalysis, polyene cyclizations mediated by (PPP)Pt2+ have also been 
examined.  The triphos pincer ligand complex has a single site for alkene 
coordination/activation and is not prone to <-hydride elimination.   The (PPP)Pt2+ was 
capable of cyclizing 1 to give a cyclic Pt-alkyl, 4 (96:4 dr).11 The addition of the weak base 
Ph2NMe served to deprotonate the phenol after trapping of the putative carbocation 
intermediate.  Reductive cleavage led to 3 as a single product, meaning the two diastereomers 
of 4 must be a result of epimers at the Pt-containing stereocenter.  This suggested that the 
competing transition states during cyclization have the chair-chair and boat-chair 
conformations shown in Scheme 3.3.  
 
10.  Nowroozi-Isfahani, T.; Musaev, D. G.; Morokuma, K.; Gagné. M. R. Organometallics. Accepted. 
 
11.  Koh, J. H.; Gagné, M. R. Angew. Chem. Int. Ed. 2004, 43, 3459-3461.  
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Scheme 3.15 
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Each of these previously developed methods has its advantages and drawbacks.  The 
PdCl2 system (eq. 3.3) is an efficient catalytic system employing a common catalyst and 
oxidant.   However, the usefulness of the oxidative cyclization products is lessened by 
mixtures of olefin isomers obtained.  Furthermore, ligand controlled asymmetric induction is 
not possible because addition of donor ligands decreases the electrophilicity of the catalyst so 
that it is unable to activate an olefin for attack by a carbon based nucleophile.  The (PPP)Pt2+ 
system (Scheme 3.3) is potentially amenable to asymmetric catalysis by modification of the 
ligand to include chirality, however, the system is not catalytic.  Experiments designed to 
facilitate turnover by protonolysis of Pt-C bond met with limited success because of the 
necessity of using a strong Brønsted acid, which catalyzed an undesired monocyclization of 
the substrate.12 
We therefore simplified the Pt2+ complex from a pincer based system to a bisphosphine 
(P2) ligated system.  This opened a second coordination site on the metal so that <-hydride 
elimination was no longer inhibited.  Use of 1 equiv. (BINAP)Pt2+ for the oxidative 
polycyclization of 1 led to 2 as a single olefin isomer (eq 3.4).   This chapter describes 
 
12.   Feducia, J. A.; Cambell, A. N.; Anthis, J. W.; Gagné, M. R. Organometallics, 2006, 25, 3114 – 3117. 
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reaction and catalyst development to render this oxidative polycyclization both catalytic and 
enantioselective.     
CH2Cl2, RT
1 equiv.[ (BINAP)Pt(NCC6F5)2][BF4]2
1 equiv. Ph2NMe
O
+ "[P2PtH][BF4]"
Not Observed
[Ph2N(H)Me][BF4]22
H
O
H
1
(3.4)
 
3.2 Results and Discussion 
A.  Turnover Development.  Recent advances in Wacker type oxidative cyclizations 
have led to Pd catalysts capable of activating and discriminating between enantiofaces of an 
alkene. Turnover is achieved via <-hydride elimination and traditional Pd(0) to Pd(II) 
oxidation protocols (O2, BQ, CuCl2, etc.).13 However, the large majority of these systems 
employ neutral Pd(II) catalysts, which as mentioned above when ligated with donor ligands 
are not electrophilic enough to activate alkenes for nucleophilic attack by weak carbon 
nucleophiles.  Hayashi has had success in developing BOXAX ligands for Pd-dication 
asymmetric Wacker cyclizations,14 however when used as a catalyst with 1, Pd2+ serves only 
to isomerize the terminal olefin into a more substituted position under a variety of conditions 
(representative experiments in Scheme 3.4).  Oxidative turnover of this type with platinum15 
catalysts or with phosphine ligands is significantly less developed.   
 
13.  (a) Stahl, S. S. Angew. Chem. Int. Ed. 2004, 43, 3400 – 3420 and  references therein.  (b) Cornell, C. N. 
Sigman, M. S. Org. Lett. 2006, 8, 4117 – 4120. 
 
14.  Ubzumi, Y.; Kato, K.; Hayashi, T. J. Org. Chem. 1998, 63, 5071 – 5075.  
 
15.   Helfer, D. S.; Atwood, J. D.; Organometallics, 2004, 23, 2412 – 2420. 
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Scheme 3.16 
CH2Cl2, RT
1 equiv.[(BINAP)Pd][BF4]2
1 equiv. Ph2NMeO
H
1 10% [(BOXAX)Pd(MeCN)2][BF4]2
1 atm. O2
O
H
N
O
O
N
BOXAX
Predictably, the use of such traditional oxidants with the P2Pt2+ catalysts failed to 
generate a catalytic system.  Therefore, we reconsidered the potential reactivity of the 
presumed putative cationic Pt-hydride species, which we have been unable to observe.  
Protonation of such a species to generate H2 and P2Pt2+ is likely possible, but given the 
substrates sensitivity to strong Brønsted acid, it is not a viable option for the desired 
reactivity.  However, another electrophilic reagent for the abstraction of metal hydrides, trityl 
cation (triphenyl carbenium),16 proved effective in generating turnover.  The use of two 
equivalents trityl tetrafluroborate, two equivalents Ph2NH and 10% P2Pt2+ for the 
polycyclization of 1 yielded 2 in greater than 90% conversion by GC, again as single olefin 
isomer (eq. 3.5).  The amine base is necessary to trap the H+ half of the net loss of H2 from 
substrate to product; trityl cation abstraction of H- generates triphenylmethane.  The 
remaining 20% of 1 was converted to two monocyclization products, one oxidative (Wacker 
type) 5 and one mono cycloisomerization (Brønsted product) 6. Fractions of these side 
products are greatly increased if a highly polar nitro solvent (nitromethane or nitroethane) is 
 
16.  (a)  Cheng, T.; Bullock, R. M. Organometallics 2002, 21, 2325 – 2331.  (b) Cheng, T.; Bullock, R. M. J. 
Am. Chem. Soc. 1999, 121, 3150 – 3155.   (c) Chen, T.; Szalda, D. J.; Zheng, J.; Bullock, R. M. Inorg. Chem. 
2006, 45, 4712 – 4720. 
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not used (e.g. when solvent is CH2Cl2 5 and 6 account for >40% of the product mixture).  
Control experiments showed that both of these products can result from the reaction of 1 with 
trityl cation alone.   
Scheme 3.17 
EtNO2, RT
10% [(BINAP)Pt(NCC6F5)2][BF4]2
2.2 equiv. Ph2NH
O
+ Ph3CH
[Ph2NH2][BF4]
2 80% (GC)
H
O
H
1
2 equiv. [Ph3C][BF4]
+
O O
5 6
20% (GC)  
To make this protocol more convenient, we decided to replace the amine base and trityl 
cation with a trityl protected alcohol (a trityl ether).  Trityl ethers are quickly cleaved into 
alcohols and trityl cation in the presence of acid.  Because an equivalent of acid is generated 
upon each cyclization, we could generate the required amount of  trityl cation in situ using 
trityl ethers.  This not only removed the requirement for stoichiometric amine base which 
consumed the generated acid, it also decreased the concentration of highly reactive trityl 
cation in solution, thereby decreasing the possibility of unwanted trityl mediated side 
reactions. 
Triphenylmethanol and a variety of trityl ethers were screened for the polycyclization of 
1 with 10% P2Pt2+ catalyst (Table 3.1).  While triphenylmethanol was not effective in 
generating turnover, simple trityl ethers were, with the fraction of 2 having little dependence 
on the identity of the trityl ether.  The exception to this was trityl p-OMe benzyl ether, where 
multiple products that were the result of the addition of p-OMe benzyl alcohol to 1 were 
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observed.   Because most of the trityl ethers yielded similar results, we chose the simplest 
one, trityl methyl ether, as the optimum trityl cation source.   
Table 3.1. Effect of Various Trityl Ethers 
1
10% [(BINAP)Pt(NCC6F5)2][BF4]2
2 equiv. Ph3COR
EtNO2 RT
2 + 5 + 6
 
R % conversion 2:3:4(%) 
H 10% 100:0:0 
Me 100% 77:12:11 
CH2CF3 100% 73:13:14 
Ph 100% 70:16:14 
CH2(p-OMePh) 100% 11:1:00a
a Remainder of product consisted of products of the addition of p-OMeBnOH to 1.
We also screened electronic perturbations on the trityl moiety (Table 3.2).  The more 
electron rich trityl ethers undergo cleavage faster; the introduction of p-methoxy groups 
increases the rate of hydrolysis by about one order of magnitude for each p-methoxy 
substitutent.17 Results showed that the parent trityl methyl ether was optimum.  More 
electron rich trityl derivatives were not strong enough hydride abstractors. The case of the 
electron withdrawing p-Cl substitutent was also not successful, probably due to a slow  
hydrolysis rate.   
 
17.  Greene, T. W.; Wuts, P. G. M. In Protective Groups in Organic Synthesis. Wiley: New York, 1999, pp. 
102 – 106.  
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Table 3.2. Effect of Various Trityl Methyl Ether Derivatives 
1
10% [(BINAP)Pt(NCC6F5)2][BF4]2
2 equiv. Ar3COMe
EtNO2 RT
2 + 5 + 6 OMe
R1
R2
R3
Ar3COMe  
R1 R2 R3 % conversion 2:3:4(%) 
H H H 100% 77:12:11 
OMe OMe OMe 5% 100:0:0 
OMe OMe H 5% 100:0:0 
OMe H H 7% 100:0:0 
Me H H 57% 81:12:7 
Cl H H 34% 82:7:11 
The conditions were further improved by employing solid state version of the trityl 
methyl ether oxidant, a development further necessitated by difficulties in separating the final 
products away from the triphenylmethane byproduct.  Trityl methyl ether polystyrene resin 
was easily synthesized from commercially available trityl chloride resin.18 
B.  Catalyst Development.  With a convenient catalytic system developed, we turned our 
attention to optimization of the catalyst and to the discovery of a chiral catalyst for 
asymmetric induction in oxidative polycyclization. A quick screen of racemic and achiral 
ligands revealed that (dppe)PtI2, 7 was the best choice for an achiral precatalyst.   It was also 
discovered that the generating the catalyst in situ (through halide abstraction of P2PtX2 with 
AgBF4) without the addition of a labile placeholder ligand (i.e. NCC6F5) led to higher yields 
of product.  This is most likely due to slow substitution of olefin for the placeholder ligand; 
this effect is more pronounced when a 1,2-disubstituted alkene rather than a monosubstituted 
 
18.  Fréchet, J. M.; Haque, K. E. Tet. Lett. 1975, 16, 3055 – 3056. 
49
alkene (vida infra) is used at the initiating site of the polycyclization. In the same vein, 
nitroethane proved to be a better solvent than nitromethane, again probably due to 
competition of nitromethane and substrate for the catalyst’s vacant coordination sites.  
We next screened a large number of readily available chiral bis-phosphine ligands for 
generating 2 enantioselectivity (abbreviated list shown in Table 3.3).  For the chiral biaryl 
series (BINAP, OMe-BIPHEP, see Figure 2.1) of bisphosphine ligands a marked increase in 
enantioselectivity was observed for the xylyl (3,5-Me2Ph) versions over the phenyl versions 
(entries 3 vs. 1 and 5 vs. 4).  We therefore decided employ ligands with further steric bulk in 
those positions by utilizing DTBM-OMe-BIPHEP and DTMB-SEGPHOS (DTMB = 3,5-
ditertbutyl, 4-methoxy, entries 6 and 8); however, these catalyst with very bulky ligands did 
not give any conversion of 1 to 2. Moderate enantioselectivites were also observed with 
BICP and BDPP chiral bisphosphine ligands. The best ligand discovered was xylyl-
phanephos (Figure 3.1), where (xylyl-phanephos)Pt2+ catalyst yielded 2 in 75% ee.
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Table 3.3. Representative screen of bisphosphine ligands for Pt2+ catalyzed polycyclization. 
Entry P2 |% ee| of 2 
1 (S)-BINAP 7 
2 (S)-tol-BINAP 12 
3 (S)-xylyl-BINAP 48 
4 (R)-MeO-BIPHEP 12 
5 (R)-xylyl-MeO-BIPHEP 46 
6 (R)-DTBM-MeO-BIPHEP NR 
7 (R)-SEGPHOS 20 
8 (R)-DTBM-SEGPHOS NR 
9 (R)-BICP 52 
10 (R)-BDPP 41 
11 (S,S)-CHIRAPHOS 20 
12 (S)-xylyl-PHANEPHOS 75 
Conditions:  1, 10% P2PtX2 (X = Cl or I), 22% AgBF4, 2.1 equiv. Ph3COMe, EtNO2.
PAr2
PAr2
Ar = Ph (R)-SEGPHOS
Ar = 3,5-tBu2-4-OMe
(R)-DTBM-SEGPHOS
O
O
O
O
PAr2
PAr2
Ar = 3,5-Me2Ph
(S)-xylyl-PHANEPHOS
Ph2P
PPh2
H
H
(R,R)-BICP
PPh2 PPh2
(R,R)-BDPP
 
Figure 3.1.  Sample structures of chiral bisphosphine ligands screened for Pt2+ catalyzed 
polycyclization.19 
The optimum chiral precatalyst, (S)-(xylyl-phanephos)PtCl2, 8 was characterized by X-
ray crystallography.   An ORTEP representation is shown in Figure 3.2 along with selected 
bond lengths and angles.  As expected the Pt-P bonds are nearly equivalent; (Pt-P1 is 
2.2739(12) Å and Pt-P2 is 2.2749(12) Å) as are the Pt-Cl bonds (Pt-Cl is 2.3630(13) Å and 
Pt-Cl2 is 2.3521(12) Å.  The P1-Pt-P2 bond angle is 103.75(4)° as a consequence of the 10-
membered metalacycle generated by the chelate.  The complex shows little deviation from 
 
19.  For structures of binap and MeO-biphep type ligands see Figure 2.1.  
51
planarity at Pt (f bond angles = 361.3°).  The distortion in the aryl rings of the cyclophane 
backbone is evident; for example the C18-C19-C20 bond is 115.3(5)°. 
Figure 3.2.  ORTEP representation of 8.
C.  Scope and Limitations.  To further explore the polycyclization reactions a variety of 
dienol and trienol substrates were synthesized.  Generally, the dienol substrates were 
generated from coupling of 2,3-dihydrofuran and a 1-iodo-3-butene, followed by a Ni-
catalyzed addition of MeMgBr with ring opening of the dihydrofuran (Scheme 3.6).  The 
trienol substrates were synthesized from the iodo derivative of the corresponding dienol 
substrates.  
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Scheme 3.18 
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R1 = Me, R2 = H 14
R1 = H, R2 = Et 15  
Conditions: (a) MeSO2Cl/Et3N, CH2Cl2; (b) NaI, acetone; (c) tBuLi, THF; (d) MeMgBr/(PPh3)2NiCl2, toluene. 
This library of substrates was tested under the developed optimum conditions (Table 3.4).  
Monosubstituted alkene terminated dienol alcohol substrates 1 and 9 behaved similarly; both 
produced products (2 and 16) with trans ring junctions,20 were isolated in good yield and 
when 8 was employed as the precatalyst enantioselectivities of 75 and 79% ee were achieved, 
respectfully.  Additionally, tricyclic molecule 20, with trans-anti-trans relative ring junction 
stereochemistry could be generated in very good yield and 64% ee from trienol substrate 
13.21 
20.  Trans ring junction was confirmed by comparison of the 1H NMR of the hydrogenated product with the 
literature: see ref. 9 and  Nishizawa, M.; Iwamoto, Y; Takao, H.; Imagawa, H.; Sugihara, T. Org. Lett. 2000, 2, 
1685 – 1687. 
 
21.  Trans-anti-trans relative stereochemistry determined by comparison of 1H NMR of the hydrogenated 
product with the literature: see ref. 9 and Ohloff, G.; Giersch, W.; Pickenhagen, A. F.; Frei, B. Hel. Chem. Acta 
1985, 68, 2022 – 2029. 
53
Table 3.4.  Polycyclizations catalyzed by P2Pt2+ 
Substrate Product Yielda %eePrecatalyst
7
8
HO
OH (9)b
7
8
O
H
(2)(1)
O
H
(16)
OH (10)
7
8
O
H
(17)
OH (11)
7
8
O
H
(18)
OH (12)
7
8
O
H
(19)
OH
OH
OH
(13)
(14)
(15)
HO
O
H
O
H
O
H
(20)
(21)
(22)
(23) No Reaction
7
8
7
7
7
75%
79%
12%
10%
87%
64%c
4
73%
73%
84%
75%
67%
nd
65%
nd
72%
61%
90%
76%
52%
45%
Conditions: 10% 7 or 8, 22% AgBF4, 2.1 equiv. Ph3COMe (resin), EtNO2, RT.  a Isolated.  b solvent = MeNO2
c Determined for product after hydrogenation. 
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The P2Pt2+ catalyst proved capable of discriminating between not only mono and tri 
substituted alkenes, but also between 1,2-disubstituted and trisubstituted alkenes as shown by 
the success in cyclizing substrates 10-12 and 14-15, generating polycyclic products that are 
monosubstituted at C-4.  Enantioselectivity generated from use of precatalyst 8 was greatly 
depressed in dienol substrates 10 and 11, containing an E-1,2-disubstituted alkene at the 
terminus.  However, increases in enantioselectivity over the monosubstituted alkene 
terminated substrates were observed for Z-alkene terminated substrate 12 (87% ee).  This 
dependence on olefin substitution number and stereochemistry on enantioselectivity suggests 
that stereochemistry is controlled by initial alkene coordination to the catalyst.   
The relative stereochemistry of the products of the disubstituted products suggest that 
these cyclizations proceed exclusively (or nearly exclusively) through a chair transition state 
for A ring formation.  This is surprising for Z-alkene terminated substrates 12 and 15,
because a 1,3-diaxial interaction is created by a chair transition state in these substrates 
(Figure 3.3).  A boat transition state would alleviate this interaction, and is accessed in minor 
amounts for monosubstituted substrates in the stiochiometric cyclizations mediated by 
(PPP)Pt2+ (see Scheme 3.3).  Despite this, in these cyclizations the 1,3-diaxial interaction 
does not provide adequate driving force to disfavor the chair transition state enough to 
generate the seemingly accessible boat conformation.  
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Figure 3.3.  Possible and observed outcomes of chair vs. boat cyclizations for 11 and 12.
The ability to generate C-4 epimeric structures represents an important increase in 
product classes that can be accessed with this methodology.  While the C-4 geminally 
dimethylated products, a common skeleton found in natural products, could not be obtained 
(2-geranyl phenol (23) failed to cyclize), monosubstitution of the C-4 position can often 
induce large changes in properties versus molecules that are unsubstituted at C-4.  
Additionally, the C-4 epimer properties can differ.  For example, Ohloff and coworkers have 
investigated the odors of C-4 epimers of hydrogenated 21 (21-H2).20 While 21-H2 was 
described as possessing amber scent, epi-21-H2 (stereochemistry equal to 22 where the C-4 
Et is replaced with Me) was described as having a more woody odor.   Furthermore, 
unsubstituted structure 20-H2 was described possessing a more earthy scent, reminiscent of a 
freshly plowed field.  The substitution number and stereochemistry also dictate the strength 
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of the odor with triaxial structure (21-H2) stronger than both its epimer (epi-21-H2) and the 
unsubstituted 20-H2 (Figure 3.3). 
O
H
20-H2
2.4 ppb
O
H
21-H2
1.4 ppb
O
H
epi-21-H2
3.0 ppb  
Figure 3.4.  Structures available from Pt2+ trienol cyclizations and their odor threshold values.20 
D. Mechanistic Considerations.   Stoichiometric reaction of 
[(BINAP)Pt(NCC6F5)2][BF4]2 and 1 in the presence of Ph2NMe at 0 °C allows for clean 
formation of cationic Pt-alkyl intermediate, 24, in solution as a 1:1 mixture of diastereomers 
(eq. 3.5).  Upon warming above 0 °C, 24 undergoes <-hydride elimination to release 2 (eq. 
3.4); the putative cationic Pt-H species quickly decomposes and is not observed.  The 31P
NMR spectrum of 24 is shown in Figure 3.5.  The resonance for the phosphorus trans to the 
cyclic alkyl is found at ` 21.6 appearing as a triplet because of the overlapping doublet 
signals of each diastereomer.  The observed Pt-P coupling constant is 1555 Hz, typical of a 
phosphine ligand trans to an alkyl ligand for complexes of this type.22 The resonance for the 
phosphorus cis to the alkyl ligand appears at ` 14.2 appearing as two doublets, one for each 
diastereomer.  The Pt-P coupling constant is 4875 Hz, a very large value for a complex of 
this type and indicative of a very weakly bound species in the coordination site trans to this 
phosphine ligand.23 
22.   (a) Piddcock, A.; Richards, R. E.; Venanzi, L. M. J. Chem. Soc. A 1966, 1707 – 1710.  (b) Appleton, T.  
G.; Bennett, M. A. Inorg. Chem. 1978, 17, 738 – 747. 
 
23. Because of the trans effect in square planar complexes strong ligands trans to a phosphine lignad weaken 
the Pt-P bond and decrease the value of the coupling constant; therefore larger coupling constants are indicative 
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Figure 3.5.  31P NMR spectrum of 24 in CD3NO2 at 273K. 
 
of weak ligands in the trans position.  For comparison the weak ligand species [(BINAP)Pt(NCC6F5)2][BF4]2
and [(BINAP)Pt(MeNO2)2][BF4]2 exhibit P-Pt coupling constants of 3720 Hz and 4145 Hz respectively. 
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Despite the seemingly very weak ligand occupying the fourth coordination site of 24,
addition of excess amounts of good ligands such as acetonitrile and triflate anion did not 
cause any change in 24.24 We therefore hypothesized that the weak ligand was a <-H agostic 
interaction from the cyclic alkyl ligand and this interaction with Pt, although weak was 
geometrically accessible.  Such agostic interactions have been observed before  for 
bis(phosphine)Pt-alkyl cations.  Spencer has prepared a series of coordinatively unsaturated 
bis(phosphine)Pt-norbornyl cations (Scheme 3.7) and has confirmed the presence of a <-
agostic interaction by x-ray crystallography.25 The observed Pt-P coupling constants for the 
phosphine cis to the norbornyl ligand (trans to the agostic) ranged from 3866 to 5067 Hz for 
various ethylene and propylene linked alkyl phosphine ligands.    Reproducing Spencer’s 
synthesis with BINAP as the bisphosphine ligand has led to a complex with 31P NMR 
spectral data in excellent agreement with that of 24,26 lending strong evidence in support of 
an agostic interaction in 24.
Scheme 3.19. 
Pt(nbd)3 +
P
P
P
P
Pt HBF4
P
P
Pt
H
P
P
=
cy2P(CH2)2Pcy2
tBu2P(CH2)2PtBu2
cy2P(CH2)3Pcy2
tBu2P(CH2)3PtBu2
24.  CO and CN- did react with 24, however, the products have not been identified or well characterized. 
 
25.  (a) Carr, N.; Dunne, B. J.; Orpen, A. G.; Spencer, J. L.; J. Chem. Soc. Chem. Commun. 1988, 926 – 928.  
(b) Carr, N.; Mole, L.; Orpen, A. G.; Specer, J. L. J. Chem. Soc. Dalton Trans. 1992, 2653 – 2662. 
 
26.  Campbell, A. N.; Gagné, M. R.; Unpublished Results. 
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One of the major improvements of this chemistry over the PdCl2 methodology is the 
olefin regioselectivity.  An agostic interaction such as that proposed for Pt-alkyl intermediate 
24, provides an explanation for selective <-hydride elimination leading to a single olefin 
isomer of product.  As shown in Figure 3.6, the thermodynamic stability of the products can 
explain the preference in the products for the monosubstituted alkene terminated substrates 
(products 2, 16, and 20), however, for cis disubstituted alkene substrates (products 19 and 22)
the most stable isomer is not the one observed.   The trans-disubstituted alkene terminated 
substrates can only give the observed regioisomer because there is not a Pt-coplanar hydride 
at C-4 in the proposed Pt-equatorial chair intermediate (see Figure 3.3).  A kinetic preference 
for the observed regioisomer provided by preorganization through the agostic interaction 
with Pt could explain the observed regioselectivity.   
O
H
H0rel = 0 kcal/mol
O
H
H0rel = +3.56 kcal/mol
O
Et
H
H0rel = +2.31 kcal/mol
O
H
Et
H0rel = 0 kcal/mol
16 Not Observed
19 Not Observed
 
Figure 3.6.  Calculated27 relative heats of formation of possible regioisomers of products 16 (top) and 
19 (bottom). 
 
27.  MacSpartin ’04, semi-empirical, AM1. 
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Trityl cation, in addition to abstracting hydride from metal-hydrides15 is also known to 
abstract <-hydrides28 or [-hydrides29 from metal-alkyl species, to form olefin complexes and 
metal-carbenes respectfully.  Despite the fact that we have been operating under the 
assumption that <-hydride elimination followed by abstraction of the Pt-H was the turnover 
mechanism for this reaction, any of these mechanisms could be operative to generate the 
observed products.  
Scheme 3.20 
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The proposed catalytic cycle for the elimination/abstraction mechanism for the 
polycyclization of 1 is shown in Scheme 3.8.   Electrophilic activation of the terminal olefin 
by P2Pt2+ initiates cyclization and generates the cyclic cationic Pt-alkyl species (24 if P2 =
BINAP).  In the process the H+ generated cleaves Ph3COMe in to trityl cation and methanol.  
 
28.  For an example see: Laycock, D. E.; Baird, M. C. Tet. Lett. 1978, 3307 – 3308. 
 
29.  For an example see: Cooper, N. J.; Hayes, J. C. J. Am. Chem. Soc. 1982, 104, 5570 – 5572. 
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Next, “24” undergoes <-hydride elimination to generate at cationic P2Pt-hydride species.  The 
active catalyst is then regenerated by abstraction of the putative hydride from Pt. 
A second possibility is that the observed <-agostic interaction weakens the C-H bond in 
that position and the opportunistic trityl cation abstracts this hydride directly from the 
cationic Pt-alkyl (Scheme 3.9).  This generates a carbocation < to the Pt-C bond which causes 
the G1-alkyl to slip to the Pt2+ G2-olefin species, releasing 2 upon substitution by another 
molecule of 1.
Scheme 3.21.
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The third possible mechanism results from trityl cation abstraction of the hydride [ to the 
Pt-C bond (Scheme 3.10).  This results in a cationic Pt-carbene species.  While an unusual 
structure, cationic Pt(II) and Au(I) carbenes have been postulated to be key intermediates in   
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1,6-enyne cycloisomerizations.30 The product is released through a 1,2-hydride shift to 
generate the same <-cationic Pt-alkyl as proposed in the <-abstraction mechanism (Scheme 
3.9), followed by G1-G2 slippage and alkene displacement.   
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Strong circumstantial evidence suggests that elimination/abstraction is operative.   For 
example, the (PPP)Pt2+ catalysts where <-hydride elimination is inhibited are not subject to 
turnover by trityl cation.  Additionally, turnover does not occur at 0 °C, where 24 is stable to 
<-hydride elimination.  Also, the sterically demanding DTMB-SEGPHOS ligand, whose Pt2+ 
catalysts produced no conversion from 1 to 2 under catalytic conditions (see table 3.3), is 
capable of forming the cyclic Pt-alkyl cation analogous to 24. In this case the complex is 
stable to <-hydride elimination at room temperature, thus showing that the large ligand 
 
30.  López, S.; Herrero-Gómez, E.; Pérez-Galán, P; Nieto-Oberhuber, C; Echavarren, A. M. Angew. Chem. Int. 
Ed. 2006, 45, 1 – 4.  (b) Méndez, M.; Mamane, V.; Fürstner, A. Chemtracts-Org. Chem. 2003, 16, 397 – 425. 
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inhibits <-hydride elimination, not coordination and cyclization of 1. Lack of catalytic 
activity in these cases, provides further evidence that <-hydride elimination is necessary for 
catalysis.   
3.3 Conclusion 
A regio-, diastereo- and enantio-selective biomimetic oxidative polycyclization catalyzed 
by bis(phosphine)Pt-dications has been developed.  Utilization of the commercially available 
ligand xylyl-PHANEPHOS provided optimum enantioselectivities, up to 87%.  The use of 
trityl cation as the stoichiometric oxidant where traditional oxidants failed was the key 
development in generating a catalytic system.  The scope of this reaction includes various 
dienol and trienol substrates for generation of a variety of polycyclic structures.  The reaction 
also proved to be stereospecific with various epimeric products possible, dependant on the E
or Z geometry of the substrates. The proposed mechanism for this reaction involves 
electrophilic activation of the least substituted olefin of a polyenol, and cationic cyclization 
to generate a coordinatively unsaturated Pt-alkyl cation intermediate exhibiting a <-agostic 
interaction to Pt.  Selective <-hydride elimination releases the product as a single 
regioisomer.  The cycle is proposed to close via abstraction of the putative Pt-hydride by 
trityl cation.  This reaction represents an important improvement over previously developed 
late metal mediated biomimetic polycyclizations as it combines the two important features of 
efficient catalytic turnover and ligand induced stereocontrol. 
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3.4 Experimental 
General Procedures: 
Synthetic procedures were performed under nitrogen using standard Schlenk techniques 
or in a nitrogen filled glove box.  CH2Cl2, THF, and toluene were sparged with argon and 
passed through a column of activated alumina.  MeNO2 and EtNO2 were distilled from CaH2.
(S)-xylyl-PHANEPHOS was purchased from Strem and used as received.  Polycyclization 
substrates 1, 9, 13,9 23,31 Ph3COMe (and other TrOMe  derivatives),32 Ph3COMe33 resin and 
(cod)PtCl234 were prepared according to literature procedures. (dppe)PtI2 was prepared from 
dppe and (cod)PtI2.33 NMR spectra were recorded on a Bruker 400 MHz Avance; chemical 
shifts are reported in ppm and referenced to residual solvent peaks (1H and 13C) or to an 
external standard (85% H3PO4, 31P).  GC was performed on an HP-6890.  High-resolution 
mass spectrometry was performed by the Mass Spectrometry Laboratory at the University of 
North Carolina at Chapel Hill.  
Synthesis of Polycyclization Substrates: 
(3E,7E)-4-methylnona-3,7-dien-1-ol (10): A solution of MeMgBr in ether (18.2 mL, 
50.9 mmol) was added to a stirred suspension of (PPh3)2NiCl2 (556 mg, 0.85 mmol) in 60 
mL dry toluene under nitrogen.  The resulting red solution was stirred at room temperature 
for 15 min, and a solution of (E)-5-(hex-4-enyl)-2,3-dihydrofuran (2.36 g, 17.0 mmol) in 
toluene (20 mL) was added.  The mixture was then heated to reflux for 1 h.  The reaction was 
then cooled to 0 °C and transferred via cannula to a 50% aqueous solution of NaCO3. The 
 
31.  Yamad, S.; Ono, F.; Katagiri, T.; Tanaka, J. Bull. Chem. Soc. Jap. 1977, 50, 750-755. 
 
32.  Huszthy, P.; Lempert, K.; Simig, G.; Vékey, K.  J. Chem. Soc. Perkin Trans. I, 1982, 3021 – 3025.   
 
33.   Fyles, T. M.; Leznoff, C. C. Can. J. Chem. 1976, 54, 935 – 942. 
 
34.  Drew, D.; Doyle, J. R. Inorg. Syn. 1990, 28, 346-349.  
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mixture was stirred vigorously until it decolorized (30 min) and was then extracted with 
diethyl ether.  The combined extracts were dried with MgSO4 and the solvent removed in 
vacuo. The crude material was purified by column chromatography on silica gel eluted with 
9:1 hexanes: EtOAc to yield 1.97g 10 as a colorless oil (75%).  1H NMR (CDCl3, 400 MHz): 
` 5.36 (m, 2H), 5.10 (m, 1H), 3.59 (q, J = 5.6 Hz, 2H), 2.26 (q, J = 6.8 Hz, 2H), 2.07 (m, 
4H), 1.62 (d, J = 5.2 Hz, 3H), 1.61 (s, 3H).  13C NMR (100 MHz, CDCl3) `
(3E,7E)-4-methyldeca-3,7-dien-1-ol (11): A procedure similar to that used for synthesis 
of 10 was followed.  The crude material was purified by column chromatography on silica 
gel eluted with 9:1 hexanes: EtOAc to yield 11 as a colorless oil (78%).  1H NMR (CDCl3,
400 MHz): ` 5.43 (m, 1H), 5.33 (m, 1H), 5.09 (t, J = 7.2 Hz, 1H), 3.58 (q, J = 6.4 Hz, 2H), 
2.26 (q, J = 6.8 Hz, 2H), 2.08 (m, 4H),  1.95 (quintet, J = 7.2 Hz, 2H), 1.61 (s, 3H), 1.42 (t, J
= 6.0 Hz, 1H), 0.93 (t, J = 7.2 Hz, 3H).  13C{1H} NMR (100 MHz, CDCl3) ` 138.7, 132.3, 
128.6, 120.0, 62.3, 39.8, 31.4, 31.0, 25.5, 16.2, 13.9.  HRMS expected for C11H20O+H: 
169.159. Found: 169.157. 
(3E,7Z)-4-methyldeca-3,7-dien-1-ol (12): A procedure similar to that used for synthesis 
of 10 was followed.  The crude material was purified by column chromatography on silica 
gel eluted with 9:1 hexanes: EtOAc to yield 12 as a colorless oil (56%).  1H NMR (CDCl3,
400 MHz): 1H NMR (400 MHz, CDCl3) ` 5.35 (m, 1H), 5.27 (m, 1H), 5.11 (t, J = 7.2 Hz, 
1H), 3.59 (q, J = 6.0 Hz, 2H), 2.27 (q, J = 6.8 Hz, 2H), 2.13 (q, J = 7.6 Hz, 2H), 2.02 (m, 
4H), 1.62 (s, 3H), 1.44 (t, J = 5.6 Hz, 1H), 0.93 (t, J = 7.6 Hz, 3H).  13C{1H} NMR (100 
MHz, CDCl3) ` 138.6, 131.9, 128.5, 120.1, 62.3, 39.7, 31.4, 25.5, 20.5, 16.1, 14.4.  HRMS 
expected for C11H20O+H: 169.159. Found: 169.159. 
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(3E,7E,11E)-4,8-dimethyltrideca-3,7,11-trien-1-ol (14):  A procedure similar to that 
used for synthesis of 10 was followed..  The crude material was purified by column 
chromatography on silica gel eluted with 9:1 hexanes: EtOAc to yield 14 as a colorless oil 
(62%).  1H NMR (CDCl3, 400 MHz) ` 5.39 (m, 2H), 5.09 (m, 2H), 3.59 (q, J = 6.4 Hz, 2H), 
2.27 (q, J = 6.8 Hz, 2H), 2.02 (m, 8H), 1.62 (d, J = 5.2 Hz, 3H), 1.61 (s, 3H), 1.58 (s, 3H), 
1.37 (t, J = 3.2 Hz, 1H).  13C NMR (100 MHz, CDCl3): ` 138.9, 135.1, 131.1, 124.7, 124.0, 
119.8, 62.4, 39.8, 39.7, 31.5, 31.2, 26.4, 17.9, 16.2, 16.0.  HRMS expected for C15H26O+H:  
223.206.  Found: 223.205. 
(3E,7E,11Z)-4,8-dimethyltetradeca-3,7,11-trien-1-ol (15): A procedure similar to that 
used for synthesis of 10 was followed..  The crude material was purified by column 
chromatography on silica gel eluted with 9:1 hexanes: EtOAc to yield 14 as a colorless oil 
(62%). 1H NMR (400 MHz, CDCl3) ` 5.31 (m, 2H), 5.09 (m, 2H), 3.59 (q, J = 6.4 Hz, 2H), 
2.27  (q, J = 6.8 Hz, 2H), 2.09 (m, 4H), 2.00 (m, 6H), 1.62(s, 3H), 1.58 (s, 3H), 1.38 (t, J =
6.0 Hz, 1H), 0.93 (t, J = 7.2 Hz, 3H).  13C NMR (100 MHz, CDCl3) ` 138.9, 135.0, 131.6, 
128.7, 124.1, 119.8, 62.4, 39.8, 39.6, 31.4, 26.4, 25.6, 20.5, 16.2, 16.0, 14.4.  HRMS 
expected for C16H28O+H: 237.222. Found: 237.222. 
Synthesis of Precatalyst: 
(S)-(xylyl-PHANEPHOS)PtCl2 (8):  A solution of (S)-xyly-PHANEPHOS (500 mg, 
0.73 mmol) in 25 mL CH2Cl2 was slowly added to a solution of (cod)PtCl2 (272 mg, 0.73 
mmol) in 25 mL CH2Cl2. After 30 min of stirring the solvent was removed in vacuo and the 
yellow solid precipitated from CH2Cl2/hexanes and isolated by filtration on a frit.   The white 
power was then washed with generous amounts of hexanes and dried in vacuo to yield 634 
mg (91%) of 8. 31P NMR (162 MHz, CD2Cl2) `24.3 (s, JP-Pt = 3904 Hz).  1H NMR (CDCl3,
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400 MHz) ` 7.53 (d, J = 10.8 Hz, 3H), 7.48 (d, J = 17.6 Hz, 3H), 7.24 (s, 2H), 7.05 (s, 2H), 
6.45 (d, J = 8.0 Hz, 2H), 6.33 (m, 2H), 2.60 (m, 2H), 2.50 (m, 2H), 2.37 (s, 12H), 2.28 (s, 
3H).   Crystals suitable for X-ray diffraction obtained by vapor diffusion of n-pentane to a 
nearly saturated solution of 8 in CH2Cl2.
Oxidative Polycyclizations:   
General Procedure:  To a 13.3 mM solution of P2PtX2 ((S)-xylyl-PHANEPHOS)PtCl2
(8) or (dppe)PtI2 (7) (typically 0.02 mmol) in EtNO2 (or MeNO2 for susbtrates 1, 9, and 13)
was added 2.2 equiv. AgBF4. After stirring 1 h in the dark, 21.0 equiv. Ph3COMe on 
polystyrene resin, 1 equiv. Ph2NH, and 10 equiv. substrate were added and the mixture was 
stirred at room temperature in the dark until the reaction was complete by GC (typically 6-8 
h).  The reaction mixture was then quenched by passage through plug of silica gel eluted with 
ether.  Solvent was then removed in vacuo. Yields obtained with precatalyst 7 appear in 
brackets.  Enantioselectivity data for products obtained using precatalyst 8.
Trans-4A-methyl-4,4A,9,9A-tetrahydro-1H-xanthene (2).  Prepared from 1. Crude 
material purified by flash chromatography on silica gel eluted with 3:97 ethyl 
acetate:hexanes.  29.2 mg (73% yield) [29.5 mg (73% yield)].  Enantiomeric excess 
determined by GC: tR 40.4 min (major); tR 40.2 min (minor) [Agilent Cyclosil (30M x 
0.25mm), H2, 20 psi, 80 °C hold 5 min, ramp 2°C/min to 170°C] as 75%.   [[]25 = +9.8 (c
0.5, CHCl3). 1H NMR (400 MHz, CDCl3) ` 7.05 (t, J =7.6 Hz, 1H ), 7.01 (d, J = 7.6 Hz, 
1H), 6.77 (q, J = 7.6 Hz), 5.63 (m, 2H), 2.71 (dd, J = 16.4 Hz, 5.2 Hz, 1H), 2.51 (m, 1H), 
2.35 (m, 3H), 2.15 (m, 1H), 1.78 (m, 1H), 1.20 (s, 3H).  13C NMR (100 MHz, CDCl3) `
153.5, 129.3, 127.3, 125.4, 125.2, 121.5, 119.7, 117.0, 75.7, 39.9, 35.1, 31.9, 28.9, 17.4.  
HRMS expected for C14H16O+H: 201.128.  Found: 201.127.  
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Trans-7A-methyl-2,3,3A,4,7,7A-hexahydrobenzofuran (16):  Crude material purified by 
flash chromatography on silica gel with eluted with 3:97 diethyl ether:pentane.   21.0 mg 
(76% yield) [(23.0 mg (84% yield)].  Enantiomeric excess determined by GC: tR 10.0 min 
(major); tR 9.7 min (minor) [Agilent Cyclosil (30M x 0.25mm), H2, 20 psi, 80° C hold 8 min, 
ramp 20°C/min to 170°C] as 79%. [[]25 = +17.8 (c 0.5, CHCl3). 1H NMR (400 MHz, 
CDCl3) ` 5.62 (m, 2H), 3.90 (dd, J = 8.4 Hz, 3.2 Hz, 1H), 3.84 (m, 1H), 2.32 (m, 1H), 2.23 
(m, 2H), 1.96 (m, 1H), 1.64 – 1.86 (m, 3H), 0.93 (s, 3H).  13C NMR (100 MHz, CDCl3) `
126.5 (2C), 79.5, 65.0, 43.3, 40.1, 29.0, 28.4, 17.1.  HRMS expected for  C9H14O+H: 
139.112.  Found: 139.110. 
(Trans-anti)-4,7A-dimethyl-2,3,3A,4,7,7A-hexahydrobenzofuran (17):  Crude material 
purified by flash chromatography on silica gel eluted with 3:97 diethyl ether:pentane.  [20.3 
mg (67% yield)]  1H NMR (CDCl3, 400 MHz) ` 5.56 (m, 1H), 5.43 (m, 1H), 3.92 (dt, J = 9.6
Hz, 3.2 Hz, 1H), 3.83 (q, J = 8.4 Hz), 2.18 (m, 2H), 2.00 (m, 2H), 1.63 (m, 1H), 1.39 (m, 
1H), 1.04 (d, J = 6.8 Hz, 3H), 0.93 (s, 3H).  13C NMR (100 MHz, CDCl3) ` 133.2, 125.3, 
79.8, 65.2, 39.9, 34.8, 27.1, 19.7, 17.9.  HRMS expected for C10H16O+H 153.128.  Found: 
153.126. 
(Trans-anti)-4-ethyl-7A-methyl-2,3,3A,4,7,7A-hexahydrobenzofuran (18):  Crude 
material purified by flash chromatography on silica gel eluted with 3:97 diethyl 
ether:pentane.  [19.8 mg (65% yield)].  1H NMR 1H NMR (400 MHz, CDCl3) ` 5.60 (m, 
1H), 5.54 (m, 1H), 3.91 (dt, J = 8.3 Hz, 2.8 Hz, 1H), 3.84 (q, J = 8.4 Hz, 1H), 2.19 (m, 2H), 
2.00 (m, 1H), 1.86 (bm, 1H), 1.57 – 1.67 (m, 2H), 1.45 – 1.55 (m, 2H), 1.33 (m, 1H), 0.95 (s, 
3H), 0.93 (t, J = 8.0 Hz).  13C{1H} NMR (100 MHz, CDCl3) ` 130.9, 125.9, 80.0, 65.2, 48.6, 
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41.3, 40.0, 29.7, 27.3, 26.6, 17.8, 11.0. HRMS expected for C11H18O+H: 167.144. Found: 
167.142.  
(Trans-syn)-4-ethyl-7A-methyl-2,3,3A,4,7,7A-hexahydrobenzofuran (19): Crude 
material purified by flash chromatography on silica gel eluted with 3:97 diethyl 
ether:pentane.  18.5 mg (61% yield) [21.9 mg (72% yield)].  Enantiomeric excess determined 
by GC: tR 12.0 min (major); tR 11.9 min (minor) [Agilent Cyclosil (30M x 0.25mm), H2, 20 
psi, 80 °C hold 8 min, ramp 20°C/min to 170°C] as 87%. [[]25 = +61.7 (c 0.5, CHCl3). 1H
NMR (CDCl3, 400 MHz) ` 5.78 (m, 1H), 5.62 (m, 1H), 3.92 (m, 1H), 3.83 (q, J = 8.0 Hz, 
1H), 2.30 (br m, 1H), 2.20 (m, 1H), 1.98 (m, 2H), 1.56 (m, 1H), 1.29 (m, 2H), 0.99 (s, 3H), 
0.95 (t, J = 7.6 Hz, 3H).  13C NMR (100 MHz, CDCl3) ` 130.1, 124.9, 78.6, 64.6, 46.2, 40.3, 
40.1, 25.2, 21.7, 20.5, 13.2.  HRMS expected for C11H18O+H 167.144.  Found: 167.143. 
20: Crude material purified by flash chromatography on silica gel eluted with 3:97 
EtOAc:hexanes. 31.3 mg (76% yield) [(37.1 mg (90% yield)].  Enantiomeric excess 
determined for 20-H2 (vida infra) as 64%. [[]25 = +18.2 (c 0.5, CHCl3).  1H NMR (CDCl3,
400 MHz) ` 5.63 (m, 1H), 5.53 (m, 1H), 3.92 (m, 1H), 3.83 (q, J = 8.4 Hz, 1H), 1.87 (m, 
1H), 1.82 (m, 2H), 1.78 (m, 1H), 1.56 (m, 2H), 1.40 (m, 4H), 1.26 (m, 2H), 1.08 (s, 3H), 0.73 
(s, 3H).  13C NMR (100 MHz, CDCl3) ` 126.7, 125.2, 80.0, 67.8, 57.7, 42.9, 40.8, 38.6, 34.0, 
28.7, 27.5, 22.8, 20.5, 12.0.  HRMS expected for C14H22O+H: 207.175. Found: 207.173. 
20-H2: To a solution of 5 mg 20 (0.024 mmol) in 1.0 mL Et2O was added 5 mg Pd/C 
(0.002 mmol Pd).  The atmosphere was saturated with H2 (ballon) and the mixture was 
stirred under H2 for 3h.  The solution was then filtered through a PTFE filter and 
concentrated to yield 3 mg 20-H2 (60% yield).  1H NMR matched the literature data.20 
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Enantiomeric excess determined by GC: tR 48.4 min (major); tR 49.3 min (minor) [Agilent 
Cyclosil (30M x 0.25mm), H2, 7.5 psi, 135 °C isothermal] as 64%. 
21: Crude material purified by flash chromatography on silica gel eluted with 3:97 
EtOAc:hexanes. [(22.9 mg (52% yield)].  1H NMR (CDCl3, 400 MHz) ` 5.61 (m, 1H), 5.48 
(m, 1H), 3.93 (m, 1H), 3.83 (q, J = 8.4 Hz, 1H), 2.17 (m, 2H), 1.94 (m, 2H), 1.66 (m, 1H), 
1.50 (m, 4H), 1.32 (m, 2H),  1.09 (s, 3H), 0.83 (d, J = 6.4 Hz, 3H), 0.76 (s, 3H).  13C NMR 
(100 MHz, CDCl3) ` 133.1, 125.7, 79.6, 65.0, 59.0, 57.4, 46.3, 41.4, 40.4, 38.7,  25.2, 22.2, 
20.7, 15.8, 13.4.  
22. Crude material purified by flash chromatography on silica gel eluted with 3:97 
EtOAc:hexanes [(21.0 mg (45% yield)].  1H NMR (CDCl3, 400 MHz) `5.87 (m, 1H), 5.55 
(m, 1H), 3.91 (m, 1H), 3.83 (q, J = 8.0 Hz, 1H), 1.95 (m, 2H), 1.83 (m, 2H), 1.75 (m, 3H), 
1.58 (m, 4H), 1.43 (m, 2H), 1.22 (m, 2H), 1.09 (s, 3H), 0.93 (t, J = 7.6 Hz, 3H), 0.78 (s, 3H).  
13C NMR (100 MHz, CDCl3) ` 130.2, 123.8, 79.9, 64.8, 58.8, 46.3, 41.4, 40.9, 39.0, 34.5, 
25.1, 22.6, 22.2, 20.3, 15.6, 13.6.   
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Appendix A 
Crystal Structure of (S)-(xylyl-PHANEPHOS)PtCl2
(8, Chapter 3) 
 
Figure A.1 ORTEP representation of (S)-(xylyl-PHANEPHOS)PtCl2.
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Table A.1.  Bond distances (Å) for (S)-(xylyl-PHANEPHOS)PtCl2.
Bond                                         Length(Å) Bond                                         Length (Å) 
Pt(1)-P(2)  2.2739(12) 
Pt(1)-P(1)  2.2749(12) 
Pt(1)-Cl(2)  2.3521(12) 
Pt(1)-Cl(1)  2.3630(13) 
P(1)-C(9)  1.827(5) 
P(1)-C(1)  1.831(6) 
P(1)-C(17)  1.844(5) 
P(2)-C(41)  1.834(5) 
P(2)-C(29)  1.839(6) 
P(2)-C(33)  1.842(5) 
C(1)-C(6)  1.396(9) 
C(1)-C(2)  1.423(9) 
C(2)-C(3)  1.446(10) 
C(3)-C(4)  1.338(13) 
C(3)-C(7)  1.504(14) 
C(4)-C(5)  1.452(15) 
C(5)-C(6)  1.403(10) 
C(5)-C(8)  1.533(12) 
C(9)-C(10)  1.391(8) 
C(9)-C(14)  1.395(9) 
C(10)-C(11)  1.381(9) 
C(11)-C(12)  1.367(10) 
C(11)-C(15)  1.551(10) 
C(12)-C(13)  1.402(10) 
C(13)-C(14)  1.404(8) 
C(13)-C(16)  1.504(10) 
C(17)-C(18)  1.394(7) 
C(17)-C(22)  1.423(7) 
C(18)-C(19)  1.400(8) 
C(19)-C(20)  1.387(9) 
 
C(19)-C(32)  1.499(8) 
C(20)-C(21)  1.380(9) 
C(21)-C(22)  1.388(8) 
C(22)-C(23)  1.492(8) 
C(23)-C(24)  1.542(11) 
C(24)-C(25)  1.555(10) 
C(25)-C(26)  1.355(9) 
C(25)-C(30)  1.385(7) 
C(26)-C(27)  1.408(9) 
C(27)-C(28)  1.398(8) 
C(28)-C(29)  1.408(8) 
C(28)-C(31)  1.541(9) 
C(29)-C(30)  1.397(8) 
C(31)-C(32)  1.567(10) 
C(33)-C(38)  1.379(7) 
C(33)-C(34)  1.417(8) 
C(34)-C(35)  1.376(8) 
C(35)-C(36)  1.403(10) 
C(35)-C(39)  1.519(9) 
C(36)-C(37)  1.379(9) 
C(37)-C(38)  1.394(8) 
C(37)-C(40)  1.507(9) 
C(41)-C(46)  1.382(8) 
C(41)-C(42)  1.412(8) 
C(42)-C(43)  1.402(8) 
C(43)-C(44)  1.385(11) 
C(43)-C(47)  1.507(10) 
C(44)-C(45)  1.340(11) 
C(45)-C(46)  1.387(8) 
C(45)-C(48)                          1.594(11) 
Table A.2.  Bond angles (°) for (S)-(xylyl-PHANEPHOS)PtCl2.
Bonds                                      Angle (°) Bonds                                    Angle (°) 
P(2)-Pt(1)-P(1)    103.75(4) 
P(2)-Pt(1)-Cl(2) 85.54(4) 
P(1)-Pt(1)-Cl(2) 164.96(4) 
P(2)-Pt(1)-Cl(1) 170.19(5) 
P(1)-Pt(1)-Cl(1)                        84.47(5) 
Cl(2)-Pt(1)-Cl(1)   87.58(5) 
C(9)-P(1)-C(1) 108.5(3) 
C(9)-P(1)-C(17) 108.7(2) 
C(1)-P(1)-C(17) 96.1(2) 
C(9)-P(1)-Pt(1) 112.38(18) 
C(1)-P(1)-Pt(1) 108.1(2) 
C(17)-P(1)-Pt(1) 121.31(16) 
C(41)-P(2)-C(29) 111.2(3) 
C(41)-P(2)-C(33) 107.0(2) 
C(29)-P(2)-C(33) 97.7(2) 
C(41)-P(2)-Pt(1) 108.76(17) 
C(29)-P(2)-Pt(1) 117.52(18) 
C(23)-C(24)-C(25) 111.0(5) 
C(26)-C(25)-C(30) 117.5(6) 
C(26)-C(25)-C(24) 122.9(6) 
C(30)-C(25)-C(24) 118.0(6) 
C(25)-C(26)-C(27) 120.5(5) 
C(28)-C(27)-C(26) 120.9(6) 
C(27)-C(28)-C(29) 116.6(6) 
C(27)-C(28)-C(31) 116.5(6) 
C(29)-C(28)-C(31) 125.9(5) 
C(30)-C(29)-C(28) 118.9(5) 
C(30)-C(29)-P(2) 109.8(4) 
C(28)-C(29)-P(2) 131.3(5) 
C(25)-C(30)-C(29) 122.1(5) 
C(28)-C(31)-C(32) 110.9(5) 
C(19)-C(32)-C(31) 112.8(5) 
C(38)-C(33)-C(34) 117.9(5) 
C(20)-C(19)-C(32) 123.3(6) 
73
C(33)-P(2)-Pt(1) 113.88(17) 
C(6)-C(1)-C(2) 120.1(6) 
C(6)-C(1)-P(1) 119.7(5) 
C(2)-C(1)-P(1) 119.5(4) 
C(1)-C(2)-C(3) 119.3(7) 
C(4)-C(3)-C(2) 119.0(8) 
C(4)-C(3)-C(7) 120.9(8) 
C(2)-C(3)-C(7) 120.1(9) 
C(3)-C(4)-C(5) 122.9(7) 
C(6)-C(5)-C(4) 117.7(7) 
C(6)-C(5)-C(8) 119.5(10) 
C(4)-C(5)-C(8) 122.8(8) 
C(1)-C(6)-C(5) 120.8(8) 
C(10)-C(9)-C(14) 118.6(5) 
C(10)-C(9)-P(1) 123.9(5) 
C(14)-C(9)-P(1) 117.5(4) 
C(11)-C(10)-C(9) 122.0(6) 
C(12)-C(11)-C(10) 118.3(6) 
C(12)-C(11)-C(15) 123.4(7) 
C(10)-C(11)-C(15) 118.2(7) 
C(11)-C(12)-C(13) 122.8(5) 
C(12)-C(13)-C(14) 117.4(6) 
C(12)-C(13)-C(16) 119.4(6) 
C(14)-C(13)-C(16) 123.1(6) 
C(9)-C(14)-C(13) 120.9(6) 
C(18)-C(17)-C(22) 119.2(5) 
C(18)-C(17)-P(1) 109.7(4) 
C(22)-C(17)-P(1) 131.0(4) 
C(17)-C(18)-C(19) 122.9(5) 
C(20)-C(19)-C(18) 115.3(5) 
 
C(18)-C(19)-C(32) 119.9(5) 
C(21)-C(20)-C(19) 120.5(5) 
C(20)-C(21)-C(22) 123.6(5) 
C(21)-C(22)-C(17) 115.4(5) 
C(21)-C(22)-C(23) 116.7(5) 
C(17)-C(22)-C(23) 125.9(5) 
C(22)-C(23)-C(24) 116.2(6) 
C(38)-C(33)-P(2) 124.6(4) 
C(34)-C(33)-P(2) 117.5(4) 
C(35)-C(34)-C(33) 120.9(6) 
C(34)-C(35)-C(36) 119.4(6) 
C(34)-C(35)-C(39) 122.3(7) 
C(36)-C(35)-C(39) 118.3(6) 
C(37)-C(36)-C(35) 120.8(5) 
C(36)-C(37)-C(38) 118.7(5) 
C(36)-C(37)-C(40) 119.9(6) 
C(38)-C(37)-C(40) 121.3(6) 
C(33)-C(38)-C(37) 122.2(5) 
C(46)-C(41)-C(42) 119.9(5) 
C(46)-C(41)-P(2) 118.7(4) 
C(42)-C(41)-P(2) 121.4(4) 
C(43)-C(42)-C(41) 119.2(6) 
C(44)-C(43)-C(42) 118.4(6) 
C(44)-C(43)-C(47) 121.5(6) 
C(42)-C(43)-C(47) 120.1(7) 
C(45)-C(44)-C(43) 122.5(6) 
C(44)-C(45)-C(46) 120.3(6) 
C(44)-C(45)-C(48) 121.5(6) 
C(46)-C(45)-C(48) 118.2(7) 
C(41)-C(46)-C(45)         119.7(6) 
Table A.3 Torsion angles (Å) for (S)-(xylyl-PHANEPHOS)PtCl2.
Bonds                                       Angle (°) Bonds                                      Angle (°) 
P(2)-Pt(1)-P(1)-C(9) 124.0(2) 
Cl(2)-Pt(1)-P(1)-C(9) -109.0(3) 
Cl(1)-Pt(1)-P(1)-C(9) -50.5(2) 
P(2)-Pt(1)-P(1)-C(1) -116.3(2) 
Cl(2)-Pt(1)-P(1)-C(1) 10.7(3) 
Cl(1)-Pt(1)-P(1)-C(1) 69.2(2) 
P(2)-Pt(1)-P(1)-C(17) -6.99(19) 
Cl(2)-Pt(1)-P(1)-C(17) 120.0(2) 
Cl(1)-Pt(1)-P(1)-C(17) 178.4(2) 
P(1)-Pt(1)-P(2)-C(41) 111.46(17) 
Cl(2)-Pt(1)-P(2)-C(41) -56.54(17) 
Cl(1)-Pt(1)-P(2)-C(41) -102.1(3) 
P(1)-Pt(1)-P(2)-C(29) -16.0(2) 
Cl(2)-Pt(1)-P(2)-C(29) 176.0(2) 
Cl(1)-Pt(1)-P(2)-C(29) 130.5(3) 
P(1)-Pt(1)-P(2)-C(33) -129.29(17) 
Cl(2)-Pt(1)-P(2)-C(33) 62.70(17) 
Cl(1)-Pt(1)-P(2)-C(33) 17.1(4) 
C(9)-P(1)-C(1)-C(6) -70.7(6) 
C(17)-P(1)-C(1)-C(6) 41.4(6) 
Pt(1)-P(1)-C(1)-C(6) 167.2(5) 
C(42)-C(41)-C(46)-C(45) 2.7(8) 
P(2)-C(41)-C(46)-C(45) -177.5(5) 
C(44)-C(45)-C(46)-C(41) -1.5(10) 
C(48)-C(45)-C(46)-C(41) -179.0(7) 
C(20)-C(21)-C(22)-C(23) -153.6(6) 
C(18)-C(17)-C(22)-C(21) -10.9(7) 
P(1)-C(17)-C(22)-C(21) 170.8(4) 
C(18)-C(17)-C(22)-C(23) 152.6(6) 
P(1)-C(17)-C(22)-C(23) -25.8(8) 
C(21)-C(22)-C(23)-C(24) 79.7(7) 
C(17)-C(22)-C(23)-C(24) -83.5(8) 
C(22)-C(23)-C(24)-C(25) 6.2(8) 
C(23)-C(24)-C(25)-C(26) -88.2(7) 
C(23)-C(24)-C(25)-C(30) 76.9(7) 
C(30)-C(25)-C(26)-C(27) -12.7(8) 
C(24)-C(25)-C(26)-C(27) 152.5(6) 
C(25)-C(26)-C(27)-C(28) -3.8(9) 
C(26)-C(27)-C(28)-C(29) 16.2(9) 
C(26)-C(27)-C(28)-C(31) -153.4(6) 
C(27)-C(28)-C(29)-C(30) -12.1(8) 
C(31)-C(28)-C(29)-C(30) 156.4(6) 
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C(9)-P(1)-C(1)-C(2) 118.7(5) 
C(17)-P(1)-C(1)-C(2) -129.2(5) 
Pt(1)-P(1)-C(1)-C(2) -3.4(6) 
C(6)-C(1)-C(2)-C(3) -2.0(11) 
P(1)-C(1)-C(2)-C(3) 168.6(6) 
C(1)-C(2)-C(3)-C(4) 4.4(13) 
C(1)-C(2)-C(3)-C(7) -177.7(9) 
C(2)-C(3)-C(4)-C(5) -3.2(16) 
C(7)-C(3)-C(4)-C(5) 179.0(10) 
C(3)-C(4)-C(5)-C(6) -0.4(15) 
C(3)-C(4)-C(5)-C(8) 178.5(9) 
C(2)-C(1)-C(6)-C(5) -1.8(10) 
P(1)-C(1)-C(6)-C(5) -172.3(6) 
C(4)-C(5)-C(6)-C(1) 3.0(11) 
C(8)-C(5)-C(6)-C(1) -175.9(7) 
C(1)-P(1)-C(9)-C(10) 22.5(6) 
C(17)-P(1)-C(9)-C(10) -80.9(5) 
Pt(1)-P(1)-C(9)-C(10) 142.0(4) 
C(1)-P(1)-C(9)-C(14) -158.8(5) 
C(17)-P(1)-C(9)-C(14) 97.8(5) 
Pt(1)-P(1)-C(9)-C(14) -39.3(5) 
C(14)-C(9)-C(10)-C(11) -2.0(9) 
P(1)-C(9)-C(10)-C(11) 176.6(5) 
C(9)-C(10)-C(11)-C(12) 0.0(9) 
C(9)-C(10)-C(11)-C(15) 178.6(6) 
C(10)-C(11)-C(12)-C(13) 0.4(9) 
C(15)-C(11)-C(12)-C(13) -178.1(6) 
C(11)-C(12)-C(13)-C(14) 1.2(9) 
C(11)-C(12)-C(13)-C(16) 177.2(7) 
C(10)-C(9)-C(14)-C(13) 3.7(9) 
P(1)-C(9)-C(14)-C(13) -175.0(4) 
C(12)-C(13)-C(14)-C(9) -3.3(9) 
C(16)-C(13)-C(14)-C(9) -179.1(7) 
C(9)-P(1)-C(17)-C(18) 172.7(4) 
C(1)-P(1)-C(17)-C(18) 60.9(4) 
Pt(1)-P(1)-C(17)-C(18) -54.7(4) 
C(9)-P(1)-C(17)-C(22) -8.8(6) 
C(1)-P(1)-C(17)-C(22) -120.6(5) 
Pt(1)-P(1)-C(17)-C(22) 123.8(4) 
C(22)-C(17)-C(18)-C(19) -3.2(8) 
P(1)-C(17)-C(18)-C(19) 175.5(4) 
C(17)-C(18)-C(19)-C(20) 16.8(8) 
C(17)-C(18)-C(19)-C(32) -149.6(6) 
C(18)-C(19)-C(20)-C(21) -16.3(8) 
C(32)-C(19)-C(20)-C(21) 149.6(6) 
C(19)-C(20)-C(21)-C(22) 2.5(10) 
C(20)-C(21)-C(22)-C(17) 11.4(9) 
C(43)-C(44)-C(45)-C(48) 175.3(8) 
 
C(27)-C(28)-C(29)-P(2) 170.9(5) 
C(31)-C(28)-C(29)-P(2) -20.5(10) 
C(41)-P(2)-C(29)-C(30) -177.4(4) 
C(33)-P(2)-C(29)-C(30) 70.9(4) 
Pt(1)-P(2)-C(29)-C(30) -51.2(4) 
C(41)-P(2)-C(29)-C(28) -0.3(6) 
C(33)-P(2)-C(29)-C(28) -112.0(6) 
Pt(1)-P(2)-C(29)-C(28) 126.0(5) 
C(26)-C(25)-C(30)-C(29) 16.9(8) 
C(24)-C(25)-C(30)-C(29) -149.1(6) 
C(28)-C(29)-C(30)-C(25) -4.2(8) 
P(2)-C(29)-C(30)-C(25) 173.3(4) 
C(27)-C(28)-C(31)-C(32) 69.9(7) 
C(29)-C(28)-C(31)-C(32) -98.7(7) 
C(20)-C(19)-C(32)-C(31) -103.5(7) 
C(18)-C(19)-C(32)-C(31) 61.8(8) 
C(28)-C(31)-C(32)-C(19) 18.2(8) 
C(41)-P(2)-C(33)-C(38) 106.0(5) 
C(29)-P(2)-C(33)-C(38) -138.9(5) 
Pt(1)-P(2)-C(33)-C(38) -14.2(5) 
C(41)-P(2)-C(33)-C(34) -74.4(4) 
C(29)-P(2)-C(33)-C(34) 40.7(4) 
Pt(1)-P(2)-C(33)-C(34) 165.4(4) 
C(38)-C(33)-C(34)-C(35) -0.9(8) 
P(2)-C(33)-C(34)-C(35) 179.5(5) 
C(33)-C(34)-C(35)-C(36) 0.0(10) 
C(33)-C(34)-C(35)-C(39) 178.8(7) 
C(34)-C(35)-C(36)-C(37) 0.0(10) 
C(39)-C(35)-C(36)-C(37) -178.9(7) 
C(35)-C(36)-C(37)-C(38) 0.9(9) 
C(35)-C(36)-C(37)-C(40) -176.4(7) 
C(34)-C(33)-C(38)-C(37) 1.8(8) 
P(2)-C(33)-C(38)-C(37) -178.6(4) 
C(36)-C(37)-C(38)-C(33) -1.8(8) 
C(40)-C(37)-C(38)-C(33) 175.4(6) 
C(29)-P(2)-C(41)-C(46) 97.4(5) 
C(33)-P(2)-C(41)-C(46) -156.9(4) 
Pt(1)-P(2)-C(41)-C(46) -33.5(4) 
C(29)-P(2)-C(41)-C(42) -82.7(5) 
C(33)-P(2)-C(41)-C(42) 22.9(5) 
Pt(1)-P(2)-C(41)-C(42) 146.4(4) 
C(46)-C(41)-C(42)-C(43) -0.3(8) 
P(2)-C(41)-C(42)-C(43) 179.8(4) 
C(41)-C(42)-C(43)-C(44) -3.1(9) 
C(41)-C(42)-C(43)-C(47) 179.4(7) 
C(42)-C(43)-C(44)-C(45) 4.4(11) 
C(47)-C(43)-C(44)-C(45) -178.2(8) 
C(43)-C(44)-C(45)-C(46) -2.1(12) 
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